Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3206)
All Articles published online
|
Mar 14, 2007 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13(10): 1579-1584 [PMID: 17461452 DOI: 10.3748/wjg.v13.i10.1579] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1579.htm |
| Number | Citing Articles |
| 1 |
Naoki Matsumoto, Yasuji Arase, Yusuke Kawamura, Miki Ohmoto-Sekine, Kazuhisa Amakawa, Kyoko Ogawa, Hiroshi Tsuji, Hsieh Shiun Dong, Shigeko Hara, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Hiromitsu Kumada, Tetsurou Kobayashi. Significance of Oral Glucose Tolerance Tests in Non-alcoholic Fatty Liver Disease Patients with a Fasting Plasma Glucose Level of <126 mg/dL and HbA1c Level of ≤6.4% in Japan. Internal Medicine 2015; 54(8): 875 doi: 10.2169/internalmedicine.54.3437
|
| 2 |
Mohammad Dehghani Firouzabadi, Amirhossein Poopak, Ali Sheikhy, Fatemeh Dehghani Firouzabadi, Fatemeh Moosaie, Soghra Rabizadeh, Sara Momtazmanesh, Manouchehr Nakhjavani, Alireza Esteghamati, Basilio Pintaudi. Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study. International Journal of Endocrinology 2024; 2024(1) doi: 10.1155/2024/5328965
|
| 3 |
Noemí Cabré, Míriam Gil, Núria Amigó, Fedra Luciano-Mateo, Gerard Baiges-Gaya, Salvador Fernández-Arroyo, Elisabet Rodríguez-Tomàs, Anna Hernández-Aguilera, Helena Castañé, Marta París, Fàtima Sabench, Daniel Del Castillo, Jordi Camps, Jorge Joven. Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-79485-7
|
| 4 |
Quentin M. Anstee, Giovanni Targher, Christopher P. Day. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology & Hepatology 2013; 10(6): 330 doi: 10.1038/nrgastro.2013.41
|
| 5 |
Dinesh Jothimani, Silas Danielraj, Gomathy Narasimhan, Ilankumaran Kaliamoorthy, Akila Rajakumar, Kumar Palaniappan, Swetha Palanichamy, Ashwin Rammohan, Hemalatha Ramachandran, Rajesh Rajalingam, Mohamed Rela. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India. Journal of Clinical and Experimental Hepatology 2022; 12(3): 908 doi: 10.1016/j.jceh.2021.09.017
|
| 6 |
Soon Shik Shin, Michung Yoon, Pei Chin Tsung, Yong Tae Lee. Gambigyeongsinhwan(1) Improves Body Weight and Lipid Metabolism in High Fat Diet-Fed Obese Animal Model. The Korea Journal of Herbology 2014; 29(1): 35 doi: 10.6116/kjh.2014.29.1.35
|
| 7 |
Michele Barone, Maria Teresa Viggiani, Annabianca Amoruso, Serafina Schiraldi, Annapaola Zito, Fiorella Devito, Francesca Cortese, Michele Gesualdo, Natale Brunetti, Alfredo Di Leo, Pietro Scicchitano, Marco Matteo Ciccone. Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/682174
|
| 8 |
Irfan Zeb, Ronit Katz, Khurram Nasir, Jingzhong Ding, Panteha Rezaeian, Matthew J. Budoff. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis. Journal of Cardiovascular Computed Tomography 2013; 7(5): 311 doi: 10.1016/j.jcct.2013.08.011
|
| 9 |
Sheila Gato, Vanessa García-Fernández, Antonio Gil-Gómez, Ángela Rojas, Rocío Montero-Vallejo, Rocío Muñoz-Hernández, Manuel Romero-Gómez. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome. European Cardiology Review 2024; 19 doi: 10.15420/ecr.2023.26
|
| 10 |
Keishi Ichikawa, Toru Miyoshi, Kazuhiro Osawa, Takashi Miki, Hironobu Toda, Kentaro Ejiri, Masatoki Yoshida, Yusuke Nanba, Masashi Yoshida, Kazufumi Nakamura, Hiroshi Morita, Hiroshi Ito. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. Cardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-020-01192-4
|
| 11 |
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 2022; 186: 109819 doi: 10.1016/j.diabres.2022.109819
|
| 12 |
Young-Sang Kim, Soo-Hyun Lee, Seung Geon Park, Bo Youn Won, Hyejin Chun, Doo-Yeoun Cho, Moon-Jong Kim, Ji Eun Lee, Ji-Hee Haam, Kunhee Han. Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults. Metabolism 2020; 103: 154026 doi: 10.1016/j.metabol.2019.154026
|
| 13 |
Soo Lim, James B. Meigs. Links Between Ectopic Fat and Vascular Disease in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology 2014; 34(9): 1820 doi: 10.1161/ATVBAHA.114.303035
|
| 14 |
Patrick S. Yachimski, Lawrence S. Friedman. Clinical Hepatology. 2010; : 1383 doi: 10.1007/978-3-642-04519-6_50
|
| 15 |
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population. Hepatology Research 2022; 52(8): 687 doi: 10.1111/hepr.13790
|
| 16 |
Shigenori Hiruma, Fumika Shigiyama, Naoki Kumashiro. Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue‐specific insulin sensitivity in patients with early‐stage type 2 diabetes with non‐alcoholic fatty liver disease: A prospective randomized study. Diabetes, Obesity and Metabolism 2023; 25(6): 1576 doi: 10.1111/dom.15006
|
| 17 |
Livnat Alon, Bernadette Corica, Valeria Raparelli, Roberto Cangemi, Stefania Basili, Marco Proietti, Giulio Francesco Romiti. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Preventive Cardiology 2022; 29(6): 938 doi: 10.1093/eurjpc/zwab212
|
| 18 |
Matthew J. Armstrong, Leon A. Adams, Ali Canbay, Wing-Kin Syn. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59(3): 1174 doi: 10.1002/hep.26717
|
| 19 |
Theodor Baars, Robert K. Gieseler, Polykarpos C. Patsalis, Ali Canbay. Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease. Metabolism 2022; 130: 155179 doi: 10.1016/j.metabol.2022.155179
|
| 20 |
Greg C.G. Hugenholtz, Patrick G. Northup, Robert J. Porte, Ton Lisman. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?. Blood Reviews 2015; 29(2): 127 doi: 10.1016/j.blre.2014.10.002
|
| 21 |
Yun Kyung Cho, Myungjin Kim, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park. Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study. Frontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1163052
|
| 22 |
Y Chang, S Ryu, B-S Suh, K E Yun, C-W Kim, S-I Cho. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. International Journal of Obesity 2012; 36(9): 1187 doi: 10.1038/ijo.2011.247
|
| 23 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular. Clínica e Investigación en Arteriosclerosis 2017; 29(3): 141 doi: 10.1016/j.arteri.2016.06.003
|
| 24 |
Muhammed Keskin, Mert İlker Hayıroğlu, Ahmet Okan Uzun, Tolga Sinan Güvenç, Sinan Şahin, Ömer Kozan. Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients With ST–Segment Elevation Myocardial Infarction. The American Journal of Cardiology 2017; 120(10): 1720 doi: 10.1016/j.amjcard.2017.07.107
|
| 25 |
Giovanna Mazzone, Carmine Morisco, Vincenzo Lembo, Giuseppe D’Argenio, Maria D’Armiento, Antonella Rossi, Carmine Del Giudice, Bruno Trimarco, Nicola Caporaso, Filomena Morisco. Dietary supplementation of vitamin D prevents the development of western diet‐induced metabolic, hepatic and cardiovascular abnormalities in rats. United European Gastroenterology Journal 2018; 6(7): 1056 doi: 10.1177/2050640618774140
|
| 26 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(3): 141 doi: 10.1016/j.artere.2016.06.001
|
| 27 |
Nemanja Jovicic, Ilija Jeftic, Ivan Jovanovic, Gordana Radosavljevic, Nebojsa Arsenijevic, Miodrag L. Lukic, Nada Pejnovic, Pratibha V. Nerurkar. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding. PLOS ONE 2015; 10(7): e0134089 doi: 10.1371/journal.pone.0134089
|
| 28 |
Konstantinos Tziomalos, Vasilios Giampatzis, Stella D Bouziana, Marianna Spanou, Maria Papadopoulou, Athinodoros Pavlidis, Stavroula Kostaki, Andreas Bozikas, Christos Savopoulos, Apostolos I Hatzitolios. Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. World Journal of Hepatology 2013; 5(11): 621-626 doi: 10.4254/wjh.v5.i11.621
|
| 29 |
Kenichiro Murayama, Michiaki Okada, Kenichi Tanaka, Chika Inadomi, Wataru Yoshioka, Yoshihito Kubotsu, Tomomi Yada, Hiroshi Isoda, Takuya Kuwashiro, Satoshi Oeda, Takumi Akiyama, Noriko Oza, Hideyuki Hyogo, Masafumi Ono, Takumi Kawaguchi, Takuji Torimura, Keizo Anzai, Yuichiro Eguchi, Hirokazu Takahashi. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees. Diagnostics 2021; 11(1): 132 doi: 10.3390/diagnostics11010132
|
| 30 |
Nilesh Toke, Ajit Rathod, Pooja Phalak, Vikas Patel. Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00348-1
|
| 31 |
Setor K. Kunutsor, Stephan J.L. Bakker, Hans Blokzijl, Robin P.F. Dullaart. Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age. Clinica Chimica Acta 2017; 466: 54 doi: 10.1016/j.cca.2017.01.008
|
| 32 |
Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. International Urology and Nephrology 2016; 48(6): 883 doi: 10.1007/s11255-016-1237-8
|
| 33 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Complicaciones extrahepáticas de la enfermedad por hígado graso no alcohólico: impacto más allá del hígado. Revista de Gastroenterología de México 2019; 84(4): 472 doi: 10.1016/j.rgmx.2019.05.004
|
| 34 |
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND Study. PLOS ONE 2019; 14(8): e0220659 doi: 10.1371/journal.pone.0220659
|
| 35 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4): 689 doi: 10.3390/diagnostics11040689
|
| 36 |
Zhiwei Zhang, Yu Zhou, Qin Lv, Kun Gao, Zhiguo Li, Qing Miao, Li Shen. Gegen Qinlian Decoction Modulates Atherosclerosis and Lipid Metabolism Through Cellular Interplay and Signaling Pathways. Combinatorial Chemistry & High Throughput Screening 2024; 27(17): 2609 doi: 10.2174/0113862073285562240305113728
|
| 37 |
James E. Everhart, Kiran M. Bambha. Fatty Liver: Think Globally. Hepatology 2010; 51(5): 1491 doi: 10.1002/hep.23659
|
| 38 |
Christopher D. Byrne, Giovanni Targher. NAFLD: A multisystem disease. Journal of Hepatology 2015; 62(1): S47 doi: 10.1016/j.jhep.2014.12.012
|
| 39 |
Briohny W. Smith, Leon A. Adams. Non-alcoholic fatty liver disease. Critical Reviews in Clinical Laboratory Sciences 2011; 48(3): 97 doi: 10.3109/10408363.2011.596521
|
| 40 |
Kayoung Lee, Jung‐Ah Sung, Jun‐Su Kim, Tae‐Jin Park. The roles of obesity and gender on the relationship between metabolic risk factors and non‐alcoholic fatty liver disease in Koreans. Diabetes/Metabolism Research and Reviews 2009; 25(2): 150 doi: 10.1002/dmrr.924
|
| 41 |
Xianghai Zhou, Yufeng Li, Xiuying Zhang, Ying Ying Guan, Yindra Puentes, Fang Zhang, Elizabeth K. Speliotes, Linong Ji. Independent markers of nonalcoholic fatty liver disease in a gentrifying population‐based Chinese cohort. Diabetes/Metabolism Research and Reviews 2019; 35(5) doi: 10.1002/dmrr.3156
|
| 42 |
Hyunji Oh, Hyun Jeong Park, Jiyun Oh, Eun Sun Lee, Sung Bin Park, Min Jae Cha, Soohyun Ahn. Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications. Ultrasonography 2022; 41(2): 335 doi: 10.14366/usg.21099
|
| 43 |
Morgana Mongraw-Chaffin, Unjali P. Gujral, Alka M. Kanaya, Namratha R. Kandula, John Jeffrey Carr, Cheryl A.M. Anderson. Relation of Ectopic Fat with Atherosclerotic Cardiovascular Disease Risk Score in South Asians Living in the United States (from the Mediators of Atherosclerosis in South Asians Living in America [MASALA] Study). The American Journal of Cardiology 2018; 121(3): 315 doi: 10.1016/j.amjcard.2017.10.026
|
| 44 |
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman, Peter P. Toth. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2022; 42(6) doi: 10.1161/ATV.0000000000000153
|
| 45 |
Jacqueline G. O'Leary, Patrick S. Yachimski, Lawrence S. Friedman. Surgery in the Patient with Liver Disease. Clinics in Liver Disease 2009; 13(2): 211 doi: 10.1016/j.cld.2009.02.002
|
| 46 |
W. Nseir, A. Shalata, A. Marmor, N. Assy. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease. Digestive Diseases and Sciences 2011; 56(12): 3439 doi: 10.1007/s10620-011-1767-y
|
| 47 |
Bo-Kyeong Kang, Mimi Kim, Su-Jin Shin, Yong Joo Kim. Correlation of Clinical and Histopathologic Parameters with Ultrasonographic Grades in Pediatric Non-Alcoholic Fatty Liver Disease. Journal of Korean Medical Science 2019; 34(47) doi: 10.3346/jkms.2019.34.e298
|
| 48 |
Amanda Wieland, Ruhail Kohli. Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends. American Journal of Gastroenterology 2018; 113(11): 1588 doi: 10.1038/s41395-018-0373-4
|
| 49 |
Licia Polimeni, Maria Del Ben, Francesco Baratta, Ludovica Perri, Fabiana Albanese, Daniele Pastori, Francesco Violi, Francesco Angelico. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World Journal of Hepatology 2015; 7(10): 1325-1336 doi: 10.4254/wjh.v7.i10.1325
|
| 50 |
Dawn M. Torres, Stephen A. Harrison. Diagnosis and Therapy of Nonalcoholic Steatohepatitis. Gastroenterology 2008; 134(6): 1682 doi: 10.1053/j.gastro.2008.02.077
|
| 51 |
M. A. Edens, F. Kuipers, R. P. Stolk. Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obesity Reviews 2009; 10(4): 412 doi: 10.1111/j.1467-789X.2009.00594.x
|
| 52 |
Ji Sun Nam, Sehee Jo, Shinae Kang, Chul Woo Ahn, Kyung Rae Kim, Jong Suk Park. Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults. Clinica Chimica Acta 2016; 461: 14 doi: 10.1016/j.cca.2016.07.003
|
| 53 |
Toufik Mahfood Haddad, Shadi Hamdeh, Arun Kanmanthareddy, Venkata M. Alla. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S209 doi: 10.1016/j.dsx.2016.12.033
|
| 54 |
Teruki Miyake, Sakiko Yoshida, Shin Yamamoto, Shinya Furukawa, Osamu Yoshida, Sayaka Kanzaki, Hidenori Senba, Toru Ishihara, Mitsuhito Koizumi, Yoshio Tokumoto, Masashi Hirooka, Teru Kumagi, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura, Yoichi Hiasa. Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study. Internal Medicine 2018; 57(19): 2799 doi: 10.2169/internalmedicine.0167-17
|
| 55 |
Irfan Zeb, Dong Li, Khurram Nasir, Ronit Katz, Vahid N. Larijani, Matthew J. Budoff. Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study. Academic Radiology 2012; 19(7): 811 doi: 10.1016/j.acra.2012.02.022
|
| 56 |
Kyota Fukazawa. Alcoholic Cirrhosis and Coronary Artery Disease. The American Journal of Cardiology 2012; 109(2): 304 doi: 10.1016/j.amjcard.2011.10.002
|
| 57 |
Giovanni Targher, Christopher D. Byrne, Amedeo Lonardo, Giacomo Zoppini, Corrado Barbui. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. Journal of Hepatology 2016; 65(3): 589 doi: 10.1016/j.jhep.2016.05.013
|
| 58 |
Yukiko Fukuda, Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Naoto Nakamura, Akihiro Ohbora, Takahiro Kato, Takao Kojima, Michiaki Fukui. Triglycerides to high‐density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population‐based cohort study. Liver International 2016; 36(5): 713 doi: 10.1111/liv.12977
|
| 59 |
Eric P. Stahl, Devinder S. Dhindsa, Suegene K. Lee, Pratik B. Sandesara, Naga P. Chalasani, Laurence S. Sperling. Nonalcoholic Fatty Liver Disease and the Heart. Journal of the American College of Cardiology 2019; 73(8): 948 doi: 10.1016/j.jacc.2018.11.050
|
| 60 |
Mohammad Abedin, Mohammad Rahman, Sohel Sumon, Abdur Akanda, Marzuk Ahamed, Mohammad Rahman, Mohammad Sikder. Abdominal CT Scan Role out of Fatty Liver Disease: A Study in a Selected Hospital . International Journal of Medical Imaging 2024; 12(2): 28 doi: 10.11648/j.ijmi.20241202.12
|
| 61 |
Nasir Talenezhad, Farhang Mirzavandi, Shahab Rahimpour, Amir Pasha Amel Shahbaz, Mohammad Mohammadi, Mahdieh Hosseinzadeh. Empirically derived dietary pattern and odds of non-alcoholic fatty liver diseases in overweight and obese adults: a case–control study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02222-z
|
| 62 |
Seyed Moayed Alavian, Hosein Zadi. The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease. Multidisciplinary Cardiovascular Annals 2022; 13(1) doi: 10.5812/mca-121262
|
| 63 |
Amanda Tamar Schneier, Caitlin Colleen Citti, Douglas T Dieterich. Management and diagnosis of fatty liver disease. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 671 doi: 10.1586/17474124.2015.1003209
|
| 64 |
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals. Clinical and Molecular Hepatology 2022; 28(3): 483 doi: 10.3350/cmh.2021.0406
|
| 65 |
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Yasuhiro Ohshima, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui. Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study. BMJ Open 2014; 4(10): e005413 doi: 10.1136/bmjopen-2014-005413
|
| 66 |
Yoshitaka Hashimoto, Masahide Hamaguchi, Muhei Tanaka, Akihiro Obora, Takao Kojima, Michiaki Fukui. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies. Obesity Research & Clinical Practice 2018; 12(1): 4 doi: 10.1016/j.orcp.2017.12.003
|
| 67 |
Danika Krupp, Simone A. Johner, Hermann Kalhoff, Anette E. Buyken, Thomas Remer. Long-Term Dietary Potential Renal Acid Load During Adolescence Is Prospectively Associated with Indices of Nonalcoholic Fatty Liver Disease in Young Women3. The Journal of Nutrition 2012; 142(2): 313 doi: 10.3945/jn.111.150540
|
| 68 |
Wai Hoong Chang, Stefanie H. Mueller, Sheng-Chia Chung, Graham R. Foster, Alvina G. Lai. Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-021-03210-9
|
| 69 |
Jorge Espinoza-Derout, Xuesi M. Shao, Emmanuel Bankole, Kamrul M. Hasan, Norma Mtume, Yanjun Liu, Amiya P. Sinha-Hikim, Theodore C. Friedman. Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00320
|
| 70 |
Alessandro Ciavarella, Davide Gnocchi, Carlo Custodero, Gennaro Mariano Lenato, Giorgio Fiore, Carlo Sabbà, Antonio Mazzocca. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thrombosis Research 2021; 198: 139 doi: 10.1016/j.thromres.2020.12.002
|
| 71 |
文举 朱. Study on the Correlation between TyG, SAA and Atherosclerosis in Diabetic Nephropathy Patients. Advances in Clinical Medicine 2022; 12(04): 2535 doi: 10.12677/ACM.2022.124365
|
| 72 |
Stelina Alkagiet, Achilleas Papagiannis, Konstantinos Tziomalos. Associations between nonalcoholic fatty liver disease and ischemic stroke. World Journal of Hepatology 2018; 10(7): 474-478 doi: 10.4254/wjh.v10.i7.474
|
| 73 |
Ming‐Feng Xia, Hong‐Mei Yan, Wan‐Yuan He, Xiao‐Ming Li, Chao‐Lun Li, Xiu‐Zhong Yao, Ruo‐Kun Li, Meng‐Su Zeng, Xin Gao. Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method. Obesity 2012; 20(2): 444 doi: 10.1038/oby.2011.302
|
| 74 |
Nilanka Perera, Jegarajah Indrakumar, Waruni Vijitha Abeysinghe, Vihangi Fernando, W. M. C. K. Samaraweera, Jayamal Sanjaya Lawrence. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. BMC Cardiovascular Disorders 2016; 16(1) doi: 10.1186/s12872-016-0212-8
|
| 75 |
Stefan Wolter, Anna Duprée, Christina Coelius, Alexander El Gammal, Johannes Kluwe, Nina Sauer, Oliver Mann. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort. Obesity Surgery 2017; 27(1): 90 doi: 10.1007/s11695-016-2253-6
|
| 76 |
Lan N. Tu, Megan R. Showalter, Tomas Cajka, Sili Fan, Viju V. Pillai, Oliver Fiehn, Vimal Selvaraj. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05040-6
|
| 77 |
Álvaro Terán Lantarón, Javier Crespo García. Cribado de la enfermedad hepática por depósito de grasa: cómo y a quién. Gastroenterología y Hepatología 2011; 34(4): 278 doi: 10.1016/j.gastrohep.2010.11.010
|
| 78 |
Alita Mishra, Zobair M Younossi. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2012; 2(2): 135 doi: 10.1016/S0973-6883(12)60102-9
|
| 79 |
Tsui-Yen Chang, Jong-Dar Chen. Fatty Liver and Metabolic Syndrome in Nonabdominally Obese Taiwanese Adults. Asia Pacific Journal of Public Health 2012; 24(3): 472 doi: 10.1177/1010539511402191
|
| 80 |
Amiya P. Sinha-Hikim, Indrani Sinha-Hikim, Theodore C. Friedman. Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00023
|
| 81 |
Daniele Pastori, Angela Sciacqua, Rossella Marcucci, Maria Del Ben, Francesco Baratta, Francesco Violi, Pasquale Pignatelli, Mirella Saliola, Danilo Menichelli, Marco Antonio Casciaro, Francesco Angelico, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale, Laura Novelli. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study. Internal and Emergency Medicine 2021; 16(8): 2063 doi: 10.1007/s11739-021-02682-3
|
| 82 |
Aukelien C. Dimitriu-Leen, Arthur J.H.A. Scholte. Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?. Journal of Nuclear Cardiology 2017; 24(3): 900 doi: 10.1007/s12350-015-0380-4
|
| 83 |
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Judy Ching‐Lam Yeung, Chloe Yuk‐Kiu Fung, Jasmine Ka‐Lei Chan, Zoe Hoi‐Yi Chang, Chelsia Tsz‐Yan Kwan, Hiu‐Wan Lam, Jenny Limquiaco, Angel Mei‐Ling Chim, Cheuk‐Man Yu, Henry Lik‐Yuen Chan. Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. Hepatology 2016; 63(3): 754 doi: 10.1002/hep.28253
|
| 84 |
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 2011; 43(8): 617 doi: 10.3109/07853890.2010.518623
|
| 85 |
Rocío Aller de la Fuente, Natalia Mora Cuadrado, Carla Tafur, Juan Jose López Gómez, Sara Gómez de la Cuesta, María Concepción García Sánchez, Beatriz Antolin Melero, Daniel Antonio de Luis Román. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinología, Diabetes y Nutrición 2018; 65(6): 354 doi: 10.1016/j.endinu.2017.12.011
|
| 86 |
Satoko Takahashi, Marenao Tanaka, Yukimura Higashiura, Kazuma Mori, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. Endocrine Journal 2022; 69(4): 463 doi: 10.1507/endocrj.EJ21-0563
|
| 87 |
Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo, Paola Loria. Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?. Archives of Medical Research 2011; 42(5): 337 doi: 10.1016/j.arcmed.2011.08.004
|
| 88 |
Stanley M.H. Chan, Stavros Selemidis, Steven Bozinovski, Ross Vlahos. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacology & Therapeutics 2019; 198: 160 doi: 10.1016/j.pharmthera.2019.02.013
|
| 89 |
Long Wang, Fu Zhi, Beibei Gao, Jie Ni, Yihai Liu, Xuming Mo, Jinyu Huang. Association between lipid profiles and arterial stiffness: A secondary analysis based on a cross-sectional study. Journal of International Medical Research 2020; 48(7) doi: 10.1177/0300060520938188
|
| 90 |
Jianfei Mu, Fang Tan, Xianrong Zhou, Xin Zhao. Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut–liver axis in mice. Food & Function 2020; 11(10): 8707 doi: 10.1039/D0FO01823F
|
| 91 |
Christopher D. Byrne, Giovanni Targher. Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2014; 34(6): 1155 doi: 10.1161/ATVBAHA.114.303034
|
| 92 |
Nicolette Veracruz, Bilal Hameed, Sammy Saab, Robert J. Wong. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. Journal of Clinical and Experimental Hepatology 2021; 11(1): 45 doi: 10.1016/j.jceh.2020.04.018
|
| 93 |
Leon A. Adams, Quentin M. Anstee. A fatty liver leads to a broken heart?. Journal of Hepatology 2016; 65(1): 14 doi: 10.1016/j.jhep.2016.03.012
|
| 94 |
Hyuktae Kwon. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). Journal of Obesity & Metabolic Syndrome 2020; 29(1): 76 doi: 10.7570/jomes19068
|
| 95 |
Micaela Gliozzi, Jessica Maiuolo, Francesca Oppedisano, Vincenzo Mollace. The effect of bergamot polyphenolic fraction in patients with non alcoholic liver steato-hepatitis and metabolic syndrome. PharmaNutrition 2016; 4: S27 doi: 10.1016/j.phanu.2015.11.003
|
| 96 |
R. M. Bergenstal, Y. Li, T. K. Booker Porter, C. Weaver, J. Han. Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks. Diabetes, Obesity and Metabolism 2013; 15(3): 264 doi: 10.1111/dom.12026
|
| 97 |
Xinhui Wang, Junichi Hasegawa, Yoshiyuki Kitamura, Zhongzhi Wang, Akiko Matsuda, Waka Shinoda, Norimasa Miura, Koji Kimura. Effects of Hesperidin on the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats. Journal of Pharmacological Sciences 2011; 117(3): 129 doi: 10.1254/jphs.11097FP
|
| 98 |
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa, Hiroshi Ito, Giovanni Targher. Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLOS ONE 2015; 10(6): e0131138 doi: 10.1371/journal.pone.0131138
|
| 99 |
Münevver Demir, Sonja Lang, Hans‐Michael Steffen. Nonalcoholic fatty liver disease – current status and future directions. Journal of Digestive Diseases 2015; 16(10): 541 doi: 10.1111/1751-2980.12291
|
| 100 |
G. Zoppini, G. Targher, M. Trombetta, G. Lippi, M. Muggeo. Relationship between soluble CD40 ligand and γ‐glutamyltransferase concentrations in non‐drinking, young Type 1 diabetic individuals. Diabetic Medicine 2008; 25(11): 1283 doi: 10.1111/j.1464-5491.2008.02575.x
|
| 101 |
Radu Sebastian Gavril. Non-Alcoholic Fatty Liver Disease (NAFLD): A New Cardiovascular Risk Factor. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2015; 22(2): 209 doi: 10.1515/rjdnmd-2015-0026
|
| 102 |
Nitien H. Naran, Mark Haagensen, Nigel J. Crowther, Mark W. Sonderup. Steatosis in South African women: How much and why?. PLOS ONE 2018; 13(1): e0191388 doi: 10.1371/journal.pone.0191388
|
| 103 |
Kenji Tsunoda, Yuko Kai, Ken Uchida, Tsutomu Kuchiki, Toshiya Nagamatsu. Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study. BMJ Open 2014; 4(8): e005824 doi: 10.1136/bmjopen-2014-005824
|
| 104 |
Xiao-Fei Guo, Chong Wang, Ting Yang, Wen-Jun Ma, Jie Zhai, Ting Zhao, Tong-Cheng Xu, Jun Li, He Liu, Andrew J. Sinclair, Duo Li. Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21–adiponectin axis. Nutrition 2022; : 111659 doi: 10.1016/j.nut.2022.111659
|
| 105 |
Kosei Masuda, Masafumi Ono, Mitsutaka Fukumoto, Akira Hirose, Kensuke Munekage, Tsunehiro Ochi, Nobuto Okamoto, Naoki Akagi, Yasuhiro Ogawa, Toshiji Saibara. Usefulness of Technetium‐99 m‐2‐methoxy‐isobutyl‐isonitrile liver scintigraphy for evaluating disease activity of non‐alcoholic fatty liver disease. Hepatology Research 2012; 42(3): 273 doi: 10.1111/j.1872-034X.2011.00923.x
|
| 106 |
Ilkay S. Idilman, Deniz Akata, Tuncay Hazirolan, Beyza Doganay Erdogan, Kudret Aytemir, Musturay Karcaaltincaba. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A computed tomography angiography study 在2型糖尿病患者中非酒精性脂肪性肝病与严重冠心病有关：一项计算机断层扫描血管造影研究. Journal of Diabetes 2015; 7(2): 279 doi: 10.1111/1753-0407.12172
|
| 107 |
Nathalie C. Leite, Gil F. Salles, Antonio L. E. Araujo, Cristiane A. Villela‐Nogueira, Claudia R. L. Cardoso. Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus. Liver International 2009; 29(1): 113 doi: 10.1111/j.1478-3231.2008.01718.x
|
| 108 |
Adam P Levene, Robert D Goldin. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 2012; 61(2): 141 doi: 10.1111/j.1365-2559.2011.04145.x
|
| 109 |
Jianping Hu, Yong Xu, Zemin He, Hui Zhang, Xiaoqing Lian, Tiantian Zhu, Caihong Liang, Jun Li. Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis. Oncotarget 2018; 9(2): 2752 doi: 10.18632/oncotarget.22755
|
| 110 |
Young Mi Jung, Seung Mi Lee, Subeen Hong, Ja Nam Koo, Ig Hwan Oh, Byoung Jae Kim, Sun Min Kim, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Sue Shin, Errol R. Norwitz, Chan‐Wook Park, Jong Kwan Jun, Won Kim, Joong Shin Park. The risk of pregnancy‐associated hypertension in women with nonalcoholic fatty liver disease. Liver International 2020; 40(10): 2417 doi: 10.1111/liv.14563
|
| 111 |
Andrew Paul DeFilippis, Michael J. Blaha, Seth S. Martin, Robert M. Reed, Steven R. Jones, Khurram Nasir, Roger S. Blumenthal, Matthew J. Budoff. Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2013; 227(2): 429 doi: 10.1016/j.atherosclerosis.2013.01.022
|
| 112 |
Fang Yan, Qi Wang, Chao Xu, Mingfeng Cao, Xiaoming Zhou, Tingting Wang, Chunxiao Yu, Fei Jing, Wenbin Chen, Ling Gao, Jiajun Zhao, Gabriele Vincenzo Gnoni. Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect. PLoS ONE 2014; 9(6): e99245 doi: 10.1371/journal.pone.0099245
|
| 113 |
Dong Hyun Sinn, Geum-Youn Gwak, Ha Na Park, Jee Eun Kim, Yang Won Min, Kwang Min Kim, Yu Jin Kim, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults. American Journal of Gastroenterology 2012; 107(4): 561 doi: 10.1038/ajg.2011.400
|
| 114 |
R. A Eganyan. The role of non-alcoholic fatty liver disease in the development of cardiovascular diseases. CardioSomatics 2018; 9(1): 47 doi: 10.26442/CS45957
|
| 115 |
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
|
| 116 |
Joanne R. Morling, Jonathan A. Fallowfield, Rachel M. Williamson, Christine M. Robertson, Stephen Glancy, Indra N. Guha, Mark W. J. Strachan, Jackie F. Price. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabetologia 2015; 58(7): 1484 doi: 10.1007/s00125-015-3575-y
|
| 117 |
J. Bernadette Moore. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proceedings of the Nutrition Society 2010; 69(2): 211 doi: 10.1017/S0029665110000030
|
| 118 |
Jong Wook Kim, Jeong-Sik Byeon. Non-Alcoholic Fatty Liver Disease and Colonic Neoplasm. Korean Journal of Medicine 2013; 84(3): 360 doi: 10.3904/kjm.2013.84.3.360
|
| 119 |
Nam Kyoung Seo, Hyung suk Koo, Ji‐hee Haam, Hyung Yuk Kim, Moon Jong Kim, Kyung‐Chae Park, Kye‐Seon Park, Young‐Sang Kim. Prediction of prevalent but not incident non‐alcoholic fatty liver disease by levels of serum testosterone. Journal of Gastroenterology and Hepatology 2015; 30(7): 1211 doi: 10.1111/jgh.12935
|
| 120 |
Amedeo Lonardo, Silvia Sookoian, Carlos J. Pirola, Giovanni Targher. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 2016; 65(8): 1136 doi: 10.1016/j.metabol.2015.09.017
|
| 121 |
Chin-Chia Wu, Ta-Wen Hsu, Chia-Chou Yeh, Cheng-Hung Lee, Mei-Chen Lin, Chun-Ming Chang. The impact of colectomy on the risk of cardiovascular disease among patients without colorectal cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59640-w
|
| 122 |
Yun Hwan Oh, Seogsong Jeong, Sun Jae Park, Joseph C Ahn, Sang Min Park. Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean. Medicine 2023; 102(44): e35804 doi: 10.1097/MD.0000000000035804
|
| 123 |
Hsiu-Ching Hsu, Chia-Hsin Liu, Yi-Chen Tsai, Sin-Jin Li, Ching-Yi Chen, Chun-Han Chu, Ming-Fong Chen. Time-dependent cellular response in the liver and heart in a dietary-induced obese mouse model: the potential role of ER stress and autophagy. European Journal of Nutrition 2016; 55(6): 2031 doi: 10.1007/s00394-015-1017-8
|
| 124 |
Saleh A Alqahtani, Jörn M Schattenberg. NAFLD in the Elderly. Clinical Interventions in Aging 2021; : 1633 doi: 10.2147/CIA.S295524
|
| 125 |
Ji Sun Nam, Kahui Park, Su Jung Baik, Jong Suk Park. Lipoprotein(a) level predicts the development of nonalcoholic fatty liver disease in Korean adults: A retrospective longitudinal study. Medicine 2024; 103(22): e38340 doi: 10.1097/MD.0000000000038340
|
| 126 |
Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige, Atsushi Nakajima, Masashi Yoneda, Toshiji Saibara, Goshi Shiota, Isao Sakaida, Makoto Nakamuta, Toshihiko Mizuta, Hirohito Tsubouchi, Kentaro Sugano, Tooru Shimosegawa. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Journal of Gastroenterology 2015; 50(4): 364 doi: 10.1007/s00535-015-1050-7
|
| 127 |
Graziella Privitera, Luisa Spadaro, Corradina Alagona, Salvatore Calanna, Salvatore Piro, Agata Maria Rabuazzo, Francesco Purrello. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components. Acta Diabetologica 2016; 53(3): 449 doi: 10.1007/s00592-015-0816-y
|
| 128 |
Angel Brea Hernando, José Puzo Foncillas. Enfermedad del hígado graso no alcohólico y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 2010; 22(6): 259 doi: 10.1016/j.arteri.2010.10.004
|
| 129 |
Tomomi Saida, Wakaba Fukushima, Satoko Ohfuji, Kyoko Kondo, Ichiro Matsunaga, Yoshio Hirota. Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population. Journal of Gastroenterology and Hepatology 2014; 29(1): 128 doi: 10.1111/jgh.12377
|
| 130 |
Giovanni Targher, Lorenzo Bertolini, Stefano Rodella, Giuseppe Lippi, Massimo Franchini, Giacomo Zoppini, Michele Muggeo, Christopher P. Day. NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men. Obesity 2008; 16(6): 1394 doi: 10.1038/oby.2008.64
|
| 131 |
Shivank A. Madan, Febin John, Nikolaos Pyrsopoulos, Capecomorin S. Pitchumoni. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1237 doi: 10.1097/MEG.0000000000000429
|
| 132 |
Kunihiko Tominaga, Edward Fujimoto, Keiko Suzuki, Masayuki Hayashi, Masao Ichikawa, Yutaka Inaba. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environmental Health and Preventive Medicine 2009; 14(2): 142 doi: 10.1007/s12199-008-0074-5
|
| 133 |
Edward Gologorsky, Ernesto A. Pretto, Kyota Fukazawa. Coronary artery disease and its risk factors in patients presenting for liver transplantation. Journal of Clinical Anesthesia 2013; 25(8): 618 doi: 10.1016/j.jclinane.2013.06.001
|
| 134 |
Giovanni Guaraldi, Giulia Besutti, Chiara Stentarelli, Stefano Zona, Luca Nocetti, Paola Loria, Stefano Ballestri, Luisa Losi, Pietro Torricelli, Guido Ligabue. Magnetic Resonance for Quantitative Assessment of Liver Steatosis: A New Potential Tool to Monitor Antiretroviral-Drug-Related Toxicities. Antiviral Therapy 2012; 17(6): 965 doi: 10.3851/IMP2228
|
| 135 |
Giandomenico Bisaccia, Fabrizio Ricci, Mohammed Y. Khanji, Anna Sorella, Eugenia Melchiorre, Giovanni Iannetti, Kristian Galanti, Cesare Mantini, Andrea Delli Pizzi, Claudio Tana, Giulia Renda, Artur Fedorowski, Raffaele De Caterina, Sabina Gallina. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Current Problems in Cardiology 2023; 48(6): 101643 doi: 10.1016/j.cpcardiol.2023.101643
|
| 136 |
Maria Del Ben, Francesco Baratta, Licia Polimeni, Francesco Angelico. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Internal and Emergency Medicine 2012; 7(S3): 291 doi: 10.1007/s11739-012-0819-4
|
| 137 |
Shirin Hassani Zadeh, Anahita Mansoori, Mahdieh Hosseinzadeh. Relationship between dietary patterns and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1470 doi: 10.1111/jgh.15363
|
| 138 |
Ruth Chan, Vincent Wai-Sun Wong, Winnie Chiu-Wing Chu, Grace Lai-Hung Wong, Liz Sin Li, Jason Leung, Angel Mei-Ling Chim, David Ka-Wai Yeung, Mandy Man-Mei Sea, Jean Woo, Francis Ka-Leung Chan, Henry Lik-Yuen Chan, Susanne Kaser. Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy. PLOS ONE 2015; 10(9): e0139310 doi: 10.1371/journal.pone.0139310
|
| 139 |
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. Middle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
|
| 140 |
M. G. Radaelli, F. Martucci, S. Perra, S. Accornero, G. Castoldi, G. Lattuada, G. Manzoni, G. Perseghin. NAFLD/NASH in patients with type 2 diabetes and related treatment options. Journal of Endocrinological Investigation 2018; 41(5): 509 doi: 10.1007/s40618-017-0799-3
|
| 141 |
Emmelie Cansby, Elin Magnusson, Esther Nuñez-Durán, Manoj Amrutkar, Matteo Pedrelli, Paolo Parini, Jenny Hoffmann, Marcus Ståhlman, Brian W. Howell, Hanns-Ulrich Marschall, Jan Borén, Margit Mahlapuu. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2018; 38(8): 1723 doi: 10.1161/ATVBAHA.118.311241
|
| 142 |
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdominal Radiology 2017; 42(10): 2454 doi: 10.1007/s00261-017-1166-8
|
| 143 |
Junfeng Li, Weidong Hu, Jiangling Peng, Patty Wong, Fouad Kandeel, Tove Olafsen, John E. Shively. Heart Uptake of [18F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model. Pharmaceuticals 2022; 15(12): 1577 doi: 10.3390/ph15121577
|
| 144 |
Ki‐Chul Sung, Seungho Ryu, Jong‐Young Lee, Sung Ho Lee, Eun Sun Cheong, Sarah H. Wild, Christopher D. Byrne. Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time. Clinical Cardiology 2016; 39(6): 321 doi: 10.1002/clc.22529
|
| 145 |
Xiao-fei Guo, Bo Yang, Jun Tang, Duo Li. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. Clinical Nutrition 2018; 37(1): 113 doi: 10.1016/j.clnu.2017.01.003
|
| 146 |
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
|
| 147 |
Silvia Belia, Eleonora Urbani, Stefano Perni, Valeria Marsili, Graziana Lupattelli, Gaetano Vaudo, Anna Rita Roscini. Oxidative Balance in Lymphocytes From Patients With Nonalcoholic Steatohepatitis. The American Journal of the Medical Sciences 2014; 348(1): 30 doi: 10.1097/MAJ.0000000000000191
|
| 148 |
Ju Young Jung, Sung Keun Park, Jae‐Hong Ryoo, Chang‐Mo Oh, Jeong Gyu Kang, Jae‐Hon Lee, Joong‐Myung Choi. Effect of non‐alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population. Hepatology Research 2017; 47(6): 522 doi: 10.1111/hepr.12770
|
| 149 |
Atoosa Adibi, Majid Jaberzadeh-Ansari, Amir-Reza Dalili, Navid Omidifar, Masoumeh Sadeghi. Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris. Open Journal of Medical Imaging 2013; 3(03): 97 doi: 10.4236/ojmi.2013.33015
|
| 150 |
Paulo H. Harada, Isabela J.M. Bensenõr, Luciano F. Drager, Alessandra C. Goulart, José G. Mill, Paulo A. Lotufo. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. Atherosclerosis 2019; 284: 59 doi: 10.1016/j.atherosclerosis.2019.02.005
|
| 151 |
Hashimoto Yoshitaka, Masahide Hamaguchi, Takao Kojima, Takuya Fukuda, Akihiro Ohbora, Michiaki Fukui. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease. Medicine 2017; 96(18): e6712 doi: 10.1097/MD.0000000000006712
|
| 152 |
Carrie Down, Natasha Mehta, Kristen Marks. The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis. AIDS Research and Human Retroviruses 2016; 32(9): 868 doi: 10.1089/aid.2016.0051
|
| 153 |
Cecilia Söderberg, Per Stål, Johan Askling, Hans Glaumann, Greger Lindberg, Joel Marmur, Rolf Hultcrantz. Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up. Hepatology 2010; 51(2): 595 doi: 10.1002/hep.23314
|
| 154 |
Akiomi Yoshihisa, Yasuchika Takeishi. The Liver in Systemic Diseases. 2016; : 179 doi: 10.1007/978-4-431-55790-6_9
|
| 155 |
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease. Future Medicinal Chemistry 2019; 11(16): 2171 doi: 10.4155/fmc-2019-0003
|
| 156 |
Alok K. Gupta, George A. Bray, Frank L. Greenway, Corby K. Martin, William D. Johnson, Steven R. Smith. Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes. Journal of Diabetes and its Complications 2010; 24(5): 289 doi: 10.1016/j.jdiacomp.2009.05.004
|
| 157 |
Pauliina Pisto, Merja Santaniemi, Risto Bloigu, Olavi Ukkola, Y Antero Kesäniemi. Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 2014; 4(3): e004973 doi: 10.1136/bmjopen-2014-004973
|
| 158 |
Xin Xu, Linlin Lu, Quanyong Dong, Xiaolin Li, Nannan Zhang, Yongning Xin, Shiying Xuan. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0141-z
|
| 159 |
Jimmy Narayan, Haribhakti Seba Das, Preetam Nath, Ayaskanta Singh, Debakanta Mishra, Pradeep Kumar Padhi, Shivaram Prasad Singh. Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/1825142
|
| 160 |
Ramanujam Vendhan, Anandakumar Amutha, Ranjit Mohan Anjana, Ranjit Unnikrishnan, Mohan Deepa, Viswanathan Mohan. Comparison of Characteristics Between Nonobese and Overweight/Obese Subjects with Nonalcoholic Fatty Liver Disease in a South Indian Population. Diabetes Technology & Therapeutics 2014; 16(1): 48 doi: 10.1089/dia.2013.0165
|
| 161 |
Eris Ozkan, Mahmut Gok, Hakki Cetinkaya, Mustafa Kaplan, Gulizar Sahin. Comparison of focal segmental glomerulosclerosis and other primary glomerulonephrites in terms of parameters of hepatic steatosis and metabolic syndrome. International Urology and Nephrology 2023; 55(10): 2557 doi: 10.1007/s11255-023-03536-x
|
| 162 |
Taylor J.M. Dick, Iris A. Lesser, Jonathon A. Leipsic, G.B. John Mancini, Scott A. Lear. The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. Atherosclerosis 2013; 226(1): 208 doi: 10.1016/j.atherosclerosis.2012.10.040
|
| 163 |
Soo Lim. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 103 doi: 10.1002/9781118924938.ch12
|
| 164 |
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. Digestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
|
| 165 |
Alexandra D. Ogorodnikova, Unab I. Khan, Aileen P. McGinn, Irfan Zeb, Matthew J. Budoff, S.M. Harman, Virginia M. Miller, Eliot A. Brinton, JoAnn E. Manson, Howard N. Hodis, George R. Merriam, Marcelle I. Cedars, Hugh S. Taylor, Frederick Naftolin, Rogerio A. Lobo, Nanette Santoro, Rachel P. Wildman. Ectopic fat and adipokines in metabolically benign overweight/obese women: The kronos early estrogen prevention study. Obesity 2013; 21(8): 1726 doi: 10.1002/oby.20200
|
| 166 |
Tharnath Nanthirudjanar, Hidehiro Furumoto, Takashi Hirata, Tatsuya Sugawara. Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form. Lipids in Health and Disease 2013; 12(1) doi: 10.1186/1476-511X-12-73
|
| 167 |
Yao-Yao Zhou, Xiao-Dong Zhou, Sheng-Jie Wu, Xian-Qing Hu, Biao Tang, Sven van Poucke, Xiao-Yan Pan, Wen-Jun Wu, Xue-Mei Gu, Shen-Wen Fu, Ming-Hua Zheng. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(6): 631 doi: 10.1097/MEG.0000000000001075
|
| 168 |
Alessandra Carvalho Goulart, Ilka Regina Souza de Oliveira, Airlane Pereira Alencar, Maira Solange Camara dos Santos, Itamar Souza Santos, Brenda Margatho Ramos Martines, Danilo Peron Meireles, João Augusto dos Santos Martines, Giovanni Misciagna, Isabela Martins Benseñor, Paulo Andrade Lotufo. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sao Paulo Medical Journal 2015; 133(2): 115 doi: 10.1590/1516-3180.2014.9150812
|
| 169 |
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J.L. Bakker, Robin P.F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. Journal of Lipid Research 2019; 60(1): 168 doi: 10.1194/jlr.P088997
|
| 170 |
Malladi Subramanya Sharma, Jahnavi G. VITAMIN B12 DEFICIENCY IN NONALCOHOLIC FATTY LIVER DISEASE. Journal of Evolution of Medical and Dental Sciences 2014; 3(29): 8281 doi: 10.14260/jemds/2014/3043
|
| 171 |
Kyeong Sug Kim, Smi Choi-Kwon, Kihye Han. Structural Equation Modeling on Health Status in Hospital Nurses: Based on the Theory of Salutogenesis With Bio Behavioral Approach. Journal of Korean Biological Nursing Science 2015; 17(1): 50 doi: 10.7586/jkbns.2015.17.1.50
|
| 172 |
Maria Stepanova, Zobair M. Younossi. Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population. Clinical Gastroenterology and Hepatology 2012; 10(6): 646 doi: 10.1016/j.cgh.2011.12.039
|
| 173 |
Scott McHenry, Yikyung Park, Jeffrey D. Browning, Gregory Sayuk, Nicholas O. Davidson. Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2020; 18(9): 2073 doi: 10.1016/j.cgh.2020.01.020
|
| 174 |
Marcio H. Miname, Raul D. Santos. Fatty liver, inflamed blood and calcified coronary arteries: Lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al.. Atherosclerosis 2015; 239(2): 634 doi: 10.1016/j.atherosclerosis.2015.02.041
|
| 175 |
Min-Sun Kwak, Donghee Kim. Long-Term Outcomes of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2015; 14(2): 69 doi: 10.1007/s11901-015-0258-6
|
| 176 |
Alessandro Mantovani, Alessandro Csermely, Graziana Petracca, Giorgia Beatrice, Kathleen E Corey, Tracey G Simon, Christopher D Byrne, Giovanni Targher. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2021; 6(11): 903 doi: 10.1016/S2468-1253(21)00308-3
|
| 177 |
Alexander J. Kovalic, Sanjaya K. Satapathy. The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes. Clinics in Liver Disease 2018; 22(1): 141 doi: 10.1016/j.cld.2017.08.011
|
| 178 |
G. Targher, F. Marra, G. Marchesini. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008; 51(11): 1947 doi: 10.1007/s00125-008-1135-4
|
| 179 |
Tingfeng Wu, Junzhao Ye, Congxiang Shao, Yansong Lin, Wei Wang, Shiting Feng, Bihui Zhong. The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease. Clinical and Translational Gastroenterology 2022; 13(7): e00504 doi: 10.14309/ctg.0000000000000504
|
| 180 |
Rosa Lombardi, Silvia Fargion, Anna Ludovica Fracanzani. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. Digestive and Liver Disease 2019; 51(9): 1214 doi: 10.1016/j.dld.2019.05.015
|
| 181 |
Fatma E. Hassan, Aliaa E. M. K. El‐Mosallamy, Mohamed Mansour Khalifa, Samira H. Aljuaydi, Merhan E. Ali, Sara Adel Hosny, Nermeen Bastawy. Evaluating the potential impact of sodium–glucose cotransporter‐2 inhibitor “canagliflozin” on the hepatic damage triggered by hypertension in rats. Microscopy Research and Technique 2024; 87(12): 2929 doi: 10.1002/jemt.24665
|
| 182 |
Xiao-fei Guo, Wen-Jun Ma. Advances in Dietary Lipids and Human Health. 2022; : 135 doi: 10.1016/B978-0-12-823914-8.00009-4
|
| 183 |
Gianluca Perseghin. Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis. Diabetes Care 2011; 34(Supplement_2): S367 doi: 10.2337/dc11-s249
|
| 184 |
Maria Boddi, Roberto Tarquini, Marco Chiostri, Fabio Marra, Serafina Valente, Cristina Giglioli, Gian F. Gensini, Rosanna Abbate. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. European Journal of Clinical Investigation 2013; 43(5): 429 doi: 10.1111/eci.12065
|
| 185 |
F. Bonnet. La NASH augmente-t-elle le risque cardiovasculaire ?. Médecine des Maladies Métaboliques 2017; 11(8): 692 doi: 10.1016/S1957-2557(17)30165-7
|
| 186 |
Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, Yoshiyuki Suzuki, Yusuke Kawamura, Naoki Matsumoto, Norio Akuta, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji, Shiun Dong Hsieh, Kazuhisa Kato, Maho Tanabe, Kyoko Ogawa, Shigeko Hara, Tetsuro Kobayashi. The Development of Chronic Kidney Disease in Japanese Patients with Non-alcoholic Fatty Liver Disease. Internal Medicine 2011; 50(10): 1081 doi: 10.2169/internalmedicine.50.5043
|
| 187 |
Jennifer Linge, Magnus Borga, Janne West, Theresa Tuthill, Melissa R. Miller, Alexandra Dumitriu, E. Louise Thomas, Thobias Romu, Patrik Tunón, Jimmy D. Bell, Olof Dahlqvist Leinhard. Body Composition Profiling in the UK Biobank Imaging Study. Obesity 2018; 26(11): 1785 doi: 10.1002/oby.22210
|
| 188 |
Boren Jiang, Ting Gu, Kun Zhou, Yanjun Zheng, Yuyu Guo, Yingli Lu. Fatty Liver as a Potential Surrogate for Waist Circumference in the Diagnosis of Metabolic Syndrome: A Population-Based Study among Chinese Adults. International Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/7903982
|
| 189 |
Min Kyoung Kang, Byeong Hun Kang, Jong Ho Kim. Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis. Yonsei Medical Journal 2015; 56(5): 1288 doi: 10.3349/ymj.2015.56.5.1288
|
| 190 |
Bojian Zhang, Junsheng Li, Chaofan Zeng, Chuming Tao, Qiheng He, Chenglong Liu, Zhiyao Zheng, Zhikang Zhao, Siqi Mou, Wei Sun, Jia Wang, Qian Zhang, Rong Wang, Yan Zhang, Peicong Ge, Dong Zhang. Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02065-5
|
| 191 |
Haruo Nakayama, Shigetoshi Iwahasi, Toshiaki Ojima, Masao Kusano, Shigeyuki Asano, Yoshiki Sugai. Long term effects of pioglitazone therapy with nonalcoholic steatohepatitis. Kanzo 2009; 50(10): 555 doi: 10.2957/kanzo.50.555
|
| 192 |
Melynda S. Coker, Kaylee Ladd, Carl J. Murphy, Brent C. Ruby, Timothy C. Shriver, Dale A. Schoeller, Bradley R. Newcomer, Terry Bateman, Larry Bartlett, Robert H. Coker. Alaska backcountry expeditionary hunting promotes rapid improvements in metabolic biomarkers in healthy males and females. Physiological Reports 2021; 9(1) doi: 10.14814/phy2.14682
|
| 193 |
Llorenç Caballería, Guillem Pera, Lluís Rodríguez, Maria Antònia Auladell, Jesús Bernad, Santiago Canut, Pere Torán. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population. European Journal of Gastroenterology & Hepatology 2012; 24(9): 1007 doi: 10.1097/MEG.0b013e328355b87f
|
| 194 |
Giovanni Targher, Lorenzo Bertolini, Christopher Day. Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients. Diabetes Care 2007; 30(9): e95 doi: 10.2337/dc07-1009
|
| 195 |
Klementina Fon Tacer, Damjana Rozman. Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. Journal of Lipids 2011; 2011: 1 doi: 10.1155/2011/783976
|
| 196 |
Rafael Suárez del Villar-Carrero, Agustín Blanco, Lidia Daimiel Ruiz, Maria J. García-Blanco, Ramón Costa Segovia, Rocío García de la Garza, Diego Martínez-Urbistondo. Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis. Biomedicines 2024; 12(3): 692 doi: 10.3390/biomedicines12030692
|
| 197 |
Eun Young Park, Min Kyung Lim, Jin-Kyoung Oh, Heeyoun Cho, Mi Jin Bae, E. Hwa Yun, Dong-il Kim, Hai-Rim Shin, Anna Alisi. Independent and Supra-Additive Effects of Alcohol Consumption, Cigarette Smoking, and Metabolic Syndrome on the Elevation of Serum Liver Enzyme Levels. PLoS ONE 2013; 8(5): e63439 doi: 10.1371/journal.pone.0063439
|
| 198 |
Leon A Adams, Ariel E Feldstein. Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Review of Gastroenterology & Hepatology 2010; 4(5): 623 doi: 10.1586/egh.10.56
|
| 199 |
Roger K Schindhelm. Serum Alanine Aminotransferase, Metabolic Syndrome and Cardiovascular Disease in an Australian Population. The American Journal of Gastroenterology 2009; 104(11): 2857 doi: 10.1038/ajg.2009.498
|
| 200 |
Meng Wang, Ben-Gang Zhou, Yi Zhang, Xi-Fang Ren, Ling Li, Bo Li, Yao-Wei Ai. Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.812030
|
| 201 |
|
| 202 |
Indrani Sinha-Hikim, Amiya P. Sinha-Hikim, Ruoqing Shen, H. Kim, Samuel W. French, Nosratola D. Vaziri, Albert Crum, Tripathi B. Rajavashisth, Keith C. Norris. A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Experimental and Molecular Pathology 2011; 91(1): 419 doi: 10.1016/j.yexmp.2011.04.009
|
| 203 |
Masashi Okamoto, Teruki Miyake, Kohichiro Kitai, Shinya Furukawa, Shin Yamamoto, Hidenori Senba, Sayaka Kanzaki, Akiko Deguchi, Mitsuhito Koizumi, Toru Ishihara, Hiroaki Miyaoka, Osamu Yoshida, Masashi Hirooka, Teru Kumagi, Masanori Abe, Bunzo Matsuura, Yoichi Hiasa, Manlio Vinciguerra. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study. PLOS ONE 2018; 13(4): e0195147 doi: 10.1371/journal.pone.0195147
|
| 204 |
Marek Vecka, Aleš Žák, Eva Tvrzická, Magdalena Dušejovská, Barbora Staňková, Miroslav Zeman. Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk. Metabolic Syndrome and Related Disorders 2020; 18(4): 212 doi: 10.1089/met.2019.0105
|
| 205 |
Tracey G. Simon, Kathleen E. Corey, Raymond T. Chung, Robert Giugliano. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Digestive Diseases and Sciences 2016; 61(12): 3425 doi: 10.1007/s10620-016-4330-z
|
| 206 |
Min Kyung Kim, Chul Woo Ahn, Ji Sun Nam, Shinae Kang MD, Jong Suk Park, Kyung Rae Kim. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. Menopause 2015; 22(12): 1323 doi: 10.1097/GME.0000000000000503
|
| 207 |
Atul Luthra, Priyanka Nigam, Anoop Misra. Metabolic correlation and management strategies of non-alcoholic fatty liver disease: An Asian Indian perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2007; 1(4): 279 doi: 10.1016/j.dsx.2007.09.005
|
| 208 |
Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, Samuele De Minicis, Hannele Yki-Järvinen, Gianluca Svegliati-Baroni. From the metabolic syndrome to NAFLD or vice versa?. Digestive and Liver Disease 2010; 42(5): 320 doi: 10.1016/j.dld.2010.01.016
|
| 209 |
Sean W. P. Koppe, Marc Elias, Richard H. Moseley, Richard M. Green. Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009; 297(2): G378 doi: 10.1152/ajpgi.90543.2008
|
| 210 |
Kathleen E. Corey, Naga Chalasani. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2014; 12(7): 1077 doi: 10.1016/j.cgh.2013.08.014
|
| 211 |
Christoph Mahlke, Diego Hernando, Christina Jahn, Antonio Cigliano, Till Ittermann, Anne Mössler, Marie-Luise Kromrey, Grazyna Domaska, Scott B. Reeder, Jens-Peter Kühn. Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique. Journal of Magnetic Resonance Imaging 2016; 44(6): 1425 doi: 10.1002/jmri.25319
|
| 212 |
Mavidi Sunil Kumar, Akanksha Singh, Ashok Kumar Jaryal, Piyush Ranjan, K. K. Deepak, Sanjay Sharma, R. Lakshmy, R. M. Pandey, Naval K. Vikram. Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/5160754
|
| 213 |
Antonio J. Amor, Montserrat Pinyol, Elsa Solà, Marta Catalan, Montserrat Cofán, Zoe Herreras, Nuria Amigó, Rosa Gilabert, Aleix Sala-Vila, Emilio Ros, Emilio Ortega. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia. Journal of Clinical Lipidology 2017; 11(2): 551 doi: 10.1016/j.jacl.2017.02.001
|
| 214 |
Sarah Faasse, Hayley Braun, Miriam Vos. The role of NAFLD in cardiometabolic disease: an update. F1000Research 2018; 7: 170 doi: 10.12688/f1000research.12028.1
|
| 215 |
Lokpal S. Bhatia, Nicholas P. Curzen, Philip C. Calder, Christopher D. Byrne. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. European Heart Journal 2012; 33(10): 1190 doi: 10.1093/eurheartj/ehr453
|
| 216 |
Ángel Brea, Daniel Mosquera, José María Mostaza, José Luis Aranda, Jorge Argimón, Carmen Sanclemente, Rocío Mateo-Gallego, Fátima Almagro, Nuria Plana, Carlos Recarte. Hipertrigliceridemia, esteatosis hepática y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 2011; 23(2): 72 doi: 10.1016/j.arteri.2011.02.003
|
| 217 |
Mst. Rejina Afrin, Somasundaram Arumugam, Md. Azizur Rahman, Vengadeshprabhu Karuppagounder, Meilei Harima, Hiroshi Suzuki, Shizuka Miyashita, Kenji Suzuki, Kazuyuki Ueno, Hiroyuki Yoneyama, Kenichi Watanabe. Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling. International Immunopharmacology 2017; 49: 161 doi: 10.1016/j.intimp.2017.05.035
|
| 218 |
Kristine S. Alexander, Neil A. Zakai, Steven D. Lidofsky, Peter W. Callas, Suzanne E. Judd, Russell P. Tracy, Mary Cushman, Pavel Strnad. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLOS ONE 2018; 13(3): e0194153 doi: 10.1371/journal.pone.0194153
|
| 219 |
Ugur Arslan, Mustafa Yenerçağ. Relationship between non-alcoholic fatty liver disease and coronary heart disease. World Journal of Clinical Cases 2020; 8(20): 4688-4699 doi: 10.12998/wjcc.v8.i20.4688
|
| 220 |
Naoko Nakanishi, Yoshitaka Hashimoto, Takuro Okamura, Akihiro Ohbora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui. A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99036-y
|
| 221 |
Consuêlo Padilha VILAR, Helma Pinchemel COTRIM, Gesira Soares Assis FLORENTINO, Gerson BRAGAGNOLI, Paulo Adriano SCHWINGEL, Cibelle Padilha Vilar BARRETO. NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY DISEASE FROM A BRAZIL NORTHEAST AREA. Arquivos de Gastroenterologia 2015; 52(2): 111 doi: 10.1590/S0004-28032015000200007
|
| 222 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 223 |
Francis W. B. Sanders, Julian L. Griffin. De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biological Reviews 2016; 91(2): 452 doi: 10.1111/brv.12178
|
| 224 |
Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Shiv Chitturi, Yogesh Chawla, Yock Young Dan, Ajay Duseja, Jiangao Fan, Khean‐Lee Goh, Masahide Hamaguchi, Etsuko Hashimoto, Seung Up Kim, Laurentius Adrianto Lesmana, Yu‐Cheng Lin, Chun‐Jen Liu, Yen‐Hsuan Ni, Jose Sollano, Simon Kin‐Hung Wong, Grace Lai‐Hung Wong, Henry Lik‐Yuen Chan, Geoff Farrell. Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment. Journal of Gastroenterology and Hepatology 2018; 33(1): 70 doi: 10.1111/jgh.13857
|
| 225 |
En Yu, Hsin-Yin Hsu, Chun-Yuan Huang, Lee-Ching Hwang. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease. Open Medicine 2018; 13(1): 208 doi: 10.1515/med-2018-0032
|
| 226 |
V. Mohan, S. Farooq, M. Deepa, R. Ravikumar, C.S. Pitchumoni. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Research and Clinical Practice 2009; 84(1): 84 doi: 10.1016/j.diabres.2008.11.039
|
| 227 |
Pikkel Josef, Ibrahim Ali, Prober Ariel, Marmor Alon, Assy Nimer. Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). International Journal of Environmental Research and Public Health 2013; 10(8): 3409 doi: 10.3390/ijerph10083409
|
| 228 |
Ming‐Feng Xia, Hua Bian, Hong‐Mei Yan, Huan‐Dong Lin, Xin‐Xia Chang, Xiao‐Ming Li, Hui Ma, Wan‐Yuan He, Nai‐Qing Zhao, Pu Xia, Xin Gao. Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases. Obesity 2015; 23(9): 1929 doi: 10.1002/oby.21182
|
| 229 |
Fulvio Cacciapuoti, Anna Scognamiglio, Rossella Palumbo, Raffaele Forte, Federico Cacciapuoti. Silymarin in non alcoholic fatty liver disease. World Journal of Hepatology 2013; 5(3): 109-113 doi: 10.4254/wjh.v5.i3.109
|
| 230 |
Soo Lim, James B. Meigs. Ectopic fat and cardiometabolic and vascular risk. International Journal of Cardiology 2013; 169(3): 166 doi: 10.1016/j.ijcard.2013.08.077
|
| 231 |
Shukang Wang, Chengqi Zhang, Guang Zhang, Zhongshang Yuan, Yanxun Liu, Lijie Ding, Xiubin Sun, Hongying Jia, Fuzhong Xue. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open 2016; 6(6): e010342 doi: 10.1136/bmjopen-2015-010342
|
| 232 |
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up. Hepatology 2015; 61(5): 1547 doi: 10.1002/hep.27368
|
| 233 |
Hui-Hui Liu, Ye-Xuan Cao, Di Sun, Jing-Lu Jin, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Qiu-Ting Dong, Xi Zhao, Sha Li, Yan Zhang, Geng Liu, Jian-Jun Li. Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study. Clinical and Translational Gastroenterology 2019; 10(2): e00011 doi: 10.14309/ctg.0000000000000011
|
| 234 |
Ye Seul Bae, Yeon Seo Ko, Jae Moon Yun, Ah Young Eo, HaJin Kim, Xingshun Qi. Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8820445
|
| 235 |
Chien-Hua Chen, Chiu-Kue Nien, Chi-Chieh Yang, Yung-Hsiang Yeh. Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification. Digestive Diseases and Sciences 2010; 55(6): 1752 doi: 10.1007/s10620-009-0935-9
|
| 236 |
R. K. Schindhelm, M. Diamant. Endothelial dysfunction in Turkish patients with non‐alcoholic fatty liver disease. Internal Medicine Journal 2008; 38(4): 299 doi: 10.1111/j.1445-5994.2007.01606.x
|
| 237 |
Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology 2010; 53(2): 372 doi: 10.1016/j.jhep.2010.04.008
|
| 238 |
Seung Up Kim, Dongbeom Song, Ji Hoe Heo, Joonsang Yoo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han, Young Dae Kim. Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke. Atherosclerosis 2017; 260: 156 doi: 10.1016/j.atherosclerosis.2017.02.005
|
| 239 |
A. Stadlmayr, E. Aigner, B. Steger, L. Scharinger, D. Lederer, A. Mayr, M. Strasser, E. Brunner, A. Heuberger, F. Hohla, J. Steinwendner, W. Patsch, C. Datz. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. Journal of Internal Medicine 2011; 270(1): 41 doi: 10.1111/j.1365-2796.2011.02377.x
|
| 240 |
Christopher Masterjohn, Richard S Bruno. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutrition Reviews 2012; 70(1): 41 doi: 10.1111/j.1753-4887.2011.00440.x
|
| 241 |
Kaori Hosoyamada, Hirofumi Uto, Yasushi Imamura, Yasunari Hiramine, Eriko Toyokura, Yoshihiro Hidaka, Tomomi Kuwahara, Ken Kusano, Kazuto Saito, Makoto Oketani, Akio Ido, Hirohito Tsubouchi. Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetology & Metabolic Syndrome 2012; 4(1) doi: 10.1186/1758-5996-4-34
|
| 242 |
Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66(6): 1138 doi: 10.1136/gutjnl-2017-313884
|
| 243 |
Hua-Ling Zhai, Ning-Jian Wang, Bing Han, Qin Li, Yi Chen, Chun-Fang Zhu, Ying-Chao Chen, Fang-Zhen Xia, Zhen Cang, Chao-Xia Zhu, Meng Lu, Ying-Li Lu. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). British Journal of Nutrition 2016; 115(8): 1352 doi: 10.1017/S0007114516000386
|
| 244 |
Barbara Fruci, Stefania Giuliano, Angela Mazza, Roberta Malaguarnera, Antonino Belfiore. Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment. International Journal of Molecular Sciences 2013; 14(11): 22933 doi: 10.3390/ijms141122933
|
| 245 |
Jianxiong Lin, Jiehua Zheng, Xiaoqing Lin, Yexi Chen, Zhiyang Li. A Low Creatinine to Body Weight Ratio Predicts the Incident Nonalcoholic Fatty Liver Disease in Nonelderly Chinese without Obesity and Dyslipidemia: A Retrospective Study. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/4043871
|
| 246 |
Min‐Sun Kwak, Eunyoung Kim, Eun Jin Jang, Chang‐Hoon Lee. The association of non‐alcoholic fatty liver disease with lung function: A survey design analysis using propensity score. Respirology 2018; 23(1): 82 doi: 10.1111/resp.13127
|
| 247 |
Gary Huang, Dan Wang, Irfan Zeb, Matthew J. Budoff, S. Mitchell Harman, Virginia Miller, Eliot A. Brinton, Samar R. El Khoudary, JoAnn E. Manson, MaryFran R. Sowers, Howard N. Hodis, George R. Merriam, Marcelle I. Cedars, Hugh S. Taylor, Frederick Naftolin, Rogerio A. Lobo, Nanette Santoro, Rachel P. Wildman. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2012; 221(1): 198 doi: 10.1016/j.atherosclerosis.2011.12.004
|
| 248 |
Manya Prasad, Sunanda Gupta, Shiv K. Sarin. The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101277 doi: 10.1016/j.jceh.2023.08.013
|
| 249 |
Micaela Gliozzi, Cristina Carresi, Vincenzo Musolino, Ernesto Palma, Carolina Muscoli, Cristiana Vitale, Santo Gratteri, Giuseppe Muscianisi, Elzbieta Janda, Saverio Muscoli, Francesco Romeo, Salvatore Ragusa, Rocco Mollace, Ross Walker, James Ehrlich, Vincenzo Mollace. The Effect of Bergamot-Derived Polyphenolic Fraction on LDL Small Dense Particles and Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome. Advances in Biological Chemistry 2014; 4(02): 129 doi: 10.4236/abc.2014.42017
|
| 250 |
Hugo Perazzo, Thierry Poynard, Jean-François Dufour. The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clinics in Liver Disease 2014; 18(1): 233 doi: 10.1016/j.cld.2013.09.014
|
| 251 |
Rocío Aller de la Fuente, Natalia Mora Cuadrado, Carla Tafur, Juan Jose López Gómez, Sara Gómez de la Cuesta, María Concepción García Sánchez, Beatriz Antolin Melero, Daniel Antonio de Luis Román. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinología, Diabetes y Nutrición (English ed.) 2018; 65(6): 354 doi: 10.1016/j.endien.2018.05.009
|
| 252 |
Emily N. W. Yeung, Philipp Treskes, Sarah F. Martin, Jonathan R. Manning, Donald R. Dunbar, Sophie M. Rogers, Thierry Le Bihan, K. Ann Lockman, Steven D. Morley, Peter C. Hayes, Leonard J. Nelson, John N. Plevris. Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0069-3
|
| 253 |
Seyed Jalal Hashemi, Eskandar Hajiani, Shahram Dawoodi, Pezhman Alavinejad, Abdol Rahim Masjedizadeh, Seyed Masood Seyedian, Ali Akbar Shayesteh, Mohamad Abbasi. The Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With and Without Coronary Artery Disease. Jundishapur Journal of Chronic Disease Care 2016; 5(2) doi: 10.17795/jjcdc-35090
|
| 254 |
Zeynel Abidin Ozturk, Abdurrahman Kadayifci. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World Journal of Hepatology 2014; 6(4): 199-206 doi: 10.4254/wjh.v6.i4.199
|
| 255 |
Keping Peng, Zengnan Mo, Guixiang Tian. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males. The American Journal of the Medical Sciences 2017; 353(3): 236 doi: 10.1016/j.amjms.2017.01.002
|
| 256 |
Yuichiro Eguchi, Gabriel Wong, Emma (I‐Heng) Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida. Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review. JGH Open 2020; 4(5): 808 doi: 10.1002/jgh3.12349
|
| 257 |
Rohini Mehta, Munkzhul Otgonsuren, Zahra Younoszai, Hussain Allawi, Bryan Raybuck, Zobair Younossi. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease. BMJ Open Gastroenterology 2016; 3(1): e000096 doi: 10.1136/bmjgast-2016-000096
|
| 258 |
Jun Luo, Li Xu, Jiang Li, Shuiping Zhao. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. European Journal of Gastroenterology & Hepatology 2015; 27(3): 193 doi: 10.1097/MEG.0000000000000254
|
| 259 |
Sombat Treeprasertsuk, Francisco Lopez-Jimenez, Keith D. Lindor. Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease. Digestive Diseases and Sciences 2011; 56(1): 35 doi: 10.1007/s10620-010-1241-2
|
| 260 |
Naoki Shibata, Takanori Ito, Hidenori Toyoda, Akihito Tanaka, Yasuhiro Morita, Yasunori Kanzaki, Naoki Watanabe, Naoki Yoshioka, Satoshi Yasuda, Itsuro Morishima. Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(9): 2115 doi: 10.1016/j.numecd.2024.03.025
|
| 261 |
Ivan Ying, Gustavo Saposnik, Marian J. Vermeulen, Andrew Leung, Joel G. Ray. Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke. Epidemiology 2011; 22(1): 129 doi: 10.1097/EDE.0b013e3181feb50a
|
| 262 |
R. Ramesh, N. AdhishwarKumaran, V. KuzhandaiVelu, R. Reeta, M. SathishBabu, G. Niranjan. Association between Hepato-Biliary Status and HbA1C in Type 2 Diabetes Mellitus with Coronary Artery Disease (CAD). Journal of Diabetes Mellitus 2015; 5(02): 67 doi: 10.4236/jdm.2015.52008
|
| 263 |
Tommy Pacana, Michael Fuchs. The Cardiovascular Link to Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2012; 16(3): 599 doi: 10.1016/j.cld.2012.05.008
|
| 264 |
Lucia Pacifico, Michele Di Martino, Antonio De Merulis, Mario Bezzi, John Frederick Osborn, Carlo Catalano, Claudio Chiesa. Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease. Hepatology 2014; 59(2): 461 doi: 10.1002/hep.26610
|
| 265 |
Alicia Leikin-Frenkel, Ayelet Gonen, Aviv Shaish, Ilana Goldiner, Diana Leikin-Gobbi, Fred M. Konikoff, Dror Harats, Tuvia Gilat. Fatty Acid Bile Acid Conjugate Inhibits Hepatic Stearoyl Coenzyme A Desaturase and Is Non-atherogenic. Archives of Medical Research 2010; 41(6): 397 doi: 10.1016/j.arcmed.2010.09.001
|
| 266 |
Giliola Calori, Guido Lattuada, Francesca Ragogna, Maria Paola Garancini, Paolo Crosignani, Marco Villa, Emanuele Bosi, Giacomo Ruotolo, Lorenzo Piemonti, Gianluca Perseghin. Fatty liver index and mortality: The cremona study in the 15th year of follow-up. Hepatology 2011; 54(1): 145 doi: 10.1002/hep.24356
|
| 267 |
Mirella Pastore, Stefania Grimaudo, Rosaria Maria Pipitone, Giulia Lori, Chiara Raggi, Salvatore Petta, Fabio Marra. Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00604
|
| 268 |
Haneen Azzam, Stephen Malnick. Non-alcoholic fatty liver disease - the heart of the matter. World Journal of Hepatology 2015; 7(10): 1369-1376 doi: 10.4254/wjh.v7.i10.1369
|
| 269 |
Shunquan Wu, Fuquan Wu, Yingying Ding, Jun Hou, Jingfeng Bi, Zheng Zhang. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep33386
|
| 270 |
Rafeeq Ali, Kenneth Cusi. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Annals of Medicine 2009; 41(4): 265 doi: 10.1080/07853890802552437
|
| 271 |
Yusuf Yilmaz. Liver function tests: Association with cardiovascular outcomes. World Journal of Hepatology 2010; 2(4): 143-145 doi: 10.4254/wjh.v2.i4.143
|
| 272 |
Valerio Nobili, Christine Carter-Kent, Ariel E Feldstein. The role of lifestyle changes in the management of chronic liver disease. BMC Medicine 2011; 9(1) doi: 10.1186/1741-7015-9-70
|
| 273 |
Adam J. Buckley, E. Louise Thomas, Nader Lessan, Francesca M. Trovato, Guglielmo M. Trovato, Simon D. Taylor-Robinson. Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. Diabetes Research and Clinical Practice 2018; 144: 144 doi: 10.1016/j.diabres.2018.08.011
|
| 274 |
Jie Xu, Liye Dai, Yijun Zhang, Anxin Wang, Hao Li, Yilong Wang, Xia Meng, Shouling Wu, Yongjun Wang. Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events. Stroke 2021; 52(1): 103 doi: 10.1161/STROKEAHA.120.030433
|
| 275 |
A.G. Laurinavicius, M.S. Bittencourt, M.J. Blaha, F.C. Nary, N.M. Kashiwagi, R.D. Conceiçao, R.S. Meneghelo, R.R. Prado, J.A.M. Carvalho, K. Nasir, R.S. Blumenthal, R.D. Santos. Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test. QJM 2016; 109(8): 531 doi: 10.1093/qjmed/hcw003
|
| 276 |
Ling-zi Chen, Xu-bin Jing, Chao-fen Wu, Yi-cheng Zeng, Yan-chun Xie, Mu-qing Wang, Wen-xia Chen, Xi Hu, Yan-na Zhou, Xian-bin Cai, Nashwa El-Khazragy. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/6591784
|
| 277 |
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 2018; 68(2): 335 doi: 10.1016/j.jhep.2017.09.021
|
| 278 |
Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida. Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works. Hepatology Research 2021; 51(1): 19 doi: 10.1111/hepr.13583
|
| 279 |
Eric M. Przybyszewski, Giovanni Targher, Michael Roden, Kathleen E. Corey. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Clinical Liver Disease 2021; 17(1): 19 doi: 10.1002/cld.1017
|
| 280 |
Abdurrahman Kadayifci, Vivian Tan, Philip C. Ursell, Raphael B. Merriman, Nathan M. Bass. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: A comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. Journal of Hepatology 2008; 49(4): 595 doi: 10.1016/j.jhep.2008.05.024
|
| 281 |
Mary F. Feitosa, Alexander P. Reiner, Mary K. Wojczynski, Mariaelisa Graff, Kari E. North, Jeffrey J. Carr, Ingrid B. Borecki. Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. Atherosclerosis 2013; 227(2): 420 doi: 10.1016/j.atherosclerosis.2013.01.013
|
| 282 |
Neal S. Parikh, Lisa B. VanWagner, Mitchell S.V. Elkind, Jose Gutierrez. Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. Journal of the Neurological Sciences 2019; 407: 116524 doi: 10.1016/j.jns.2019.116524
|
| 283 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
|
| 284 |
Yanjun Liu, Di Shi, Yingying Tian, Yuntao Liu, Qiping Zhan, Jie Xu, Jingfeng Wang, Changhu Xue. Eicosapentaenoic Acid‐Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease. Lipids 2017; 52(2): 119 doi: 10.1007/s11745-016-4222-1
|
| 285 |
Michele Biagioli, Silvia Marchianò, Cristina Di Giorgio, Martina Bordoni, Ginevra Urbani, Rachele Bellini, Carmen Massa, Rana Sami Ullah Khan, Rosalinda Roselli, Maria Chiara Monti, Elva Morretta, Antonino Giordano, Valentina Vellecco, Mariarosaria Bucci, Asif Jilani Iqbal, Anella Saviano, Adel Abo Mansour, Patrizia Ricci, Eleonora Distrutti, Angela Zampella, Enrico Cieri, Giuseppe Cirino, Stefano Fiorucci. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease. Biochemical Pharmacology 2023; 218: 115900 doi: 10.1016/j.bcp.2023.115900
|
| 286 |
Paul Madaj, Matthew J. Budoff. Risk stratification of non-contrast CT beyond the coronary calcium scan. Journal of Cardiovascular Computed Tomography 2012; 6(5): 301 doi: 10.1016/j.jcct.2012.02.008
|
| 287 |
Lavanya Ravichandran, Shaun G Goodman, Andrew T Yan, Aurora Mendelsohn, Joel G Ray. Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis. Heart Asia 2012; 4(1): 137 doi: 10.1136/heartasia-2012-010167
|
| 288 |
Diego Lucero, Valeria Zago, Graciela I. López, Mabel Graffigna, Gustavo H. López, Hugo Fainboim, Verónica Miksztowicz, Leonardo Gómez Rosso, Susana Belli, Oscar Levalle, Gabriela Berg, Fernando Brites, Regina Wikinski, Laura Schreier. Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?. Clinica Chimica Acta 2011; 412(7-8): 587 doi: 10.1016/j.cca.2010.12.012
|
| 289 |
Ariane Mallat, Sophie Lotersztajn. Cigarette smoke exposure: A novel cofactor of NAFLD progression?. Journal of Hepatology 2009; 51(3): 430 doi: 10.1016/j.jhep.2009.05.021
|
| 290 |
Nele Friedrich, Harald J. Schneider, Ulrich John, Marcus Dörr, Sebastian E. Baumeister, Georg Homuth, Uwe Völker, Henri Wallaschofski. Correlates of Adverse Outcomes in Abdominally Obese Individuals: Findings from the Five-Year Followup of the Population-Based Study of Health in Pomerania. Journal of Obesity 2013; 2013: 1 doi: 10.1155/2013/762012
|
| 291 |
Rafael Perera, Emily McFadden, Julie McLellan, Tom Lung, Philip Clarke, Teresa Pérez, Thomas Fanshawe, Andrew Dalton, Andrew Farmer, Paul Glasziou, Osamu Takahashi, John Stevens, Les Irwig, Jennifer Hirst, Sarah Stevens, Asuka Leslie, Sachiko Ohde, Gautam Deshpande, Kevin Urayama, Brian Shine, Richard Stevens. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling. Health Technology Assessment 2015; 19(100): 1 doi: 10.3310/hta191000
|
| 292 |
Wilbert S Aronow. Nonalcoholic Fatty Liver Disease is Associated With Coronary Artery Disease and Subclinical Atherosclerosis. Future Cardiology 2016; 12(4): 393 doi: 10.2217/fca-2016-0033
|
| 293 |
Eline H. van den Berg, Alba A. B. Wolters, Robin P. F. Dullaart, Han Moshage, David Zurakowski, Vincent E. de Meijer, Hans Blokzijl. Prescription of statins in suspected non‐alcoholic fatty liver disease and high cardiovascular risk, a population‐based study. Liver International 2019; 39(7): 1343 doi: 10.1111/liv.14116
|
| 294 |
Nima Motamed, Hossein Ajdarkosh, Maral Ahmadi, Dhayaneethie Perumal, G Hossein Ashrafi, Mehdi Nikkhah, Amir Hossein Faraji, Mansooreh Maadi, Mahmoodreza Khoonsari, Nader Rezaie, Behzad Farahani, Fahimeh Safarnezhad Tameshkel, Mitra Ameli, Mahshid Panahi, Mohammad Hadi Karbalaie Niya, Farhad Zamani. Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. World Journal of Hepatology 2020; 12(6): 323-331 doi: 10.4254/wjh.v12.i6.323
|
| 295 |
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5): 1246 doi: 10.1007/s10620-016-4040-6
|
| 296 |
SHIHO ARIMA, HIROFUMI UTO, RIE IBUSUKI, RYO KUMAMOTO, SHIROU TANOUE, SEIICHI MAWATARI, KOHEI ODA, MASATSUGU NUMATA, HIROSHI FUJITA, MAKOTO OKETANI, AKIO IDO, HIROHITO TSUBOUCHI. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. International Journal of Molecular Medicine 2014; 33(1): 68 doi: 10.3892/ijmm.2013.1544
|
| 297 |
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Ulf Hammar, Per Stål, Johan Askling, Rolf Hultcrantz, Stergios Kechagias. Cardiovascular risk factors in non‐alcoholic fatty liver disease. Liver International 2019; 39(1): 197 doi: 10.1111/liv.13973
|
| 298 |
Teruki Miyake, Teru Kumagi, Masashi Hirooka, Shinya Furukawa, Mitsuhito Koizumi, Yoshio Tokumoto, Teruhisa Ueda, Shin Yamamoto, Masanori Abe, Kohichiro Kitai, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. Journal of Gastroenterology 2013; 48(3): 413 doi: 10.1007/s00535-012-0650-8
|
| 299 |
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Advances in Therapy 2017; 34(6): 1291 doi: 10.1007/s12325-017-0556-1
|
| 300 |
James Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M. Younossi, Francesco Negro. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease. Liver International 2019; 39(2): 342 doi: 10.1111/liv.13992
|
| 301 |
Hong-Gang Wang, Li-Zhen Wang, Hang-Jiang Fu, Peng Shen, Xiao-Dan Huang, Fa-Ming Zhang, Rui Xie, Xiao-Zhong Yang, Guo-Zhong Ji. Cholecystectomy does not significantly increase the risk of fatty liver disease. World Journal of Gastroenterology 2015; 21(12): 3614-3618 doi: 10.3748/wjg.v21.i12.3614
|
| 302 |
Fragkiskos G. Bersimis, Iraklis Varlamis. Classification Techniques for Medical Image Analysis and Computer Aided Diagnosis. 2019; : 31 doi: 10.1016/B978-0-12-818004-4.00002-9
|
| 303 |
Shun-Yi Shi, Fang Jia, Meng-Fei Wang, Ya-Feng Zhou, Jian-Jun Li. Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies. Current Atherosclerosis Reports 2023; 25(10): 751 doi: 10.1007/s11883-023-01146-7
|
| 304 |
Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno. Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke. Hepatology International 2022; 16(1): 81 doi: 10.1007/s12072-021-10253-z
|
| 305 |
Theodore C. Friedman, Indrani Sinha-Hikim, Meher Parveen, Sonia M. Najjar, Yanjun Liu, Michael Mangubat, Chang-Sung Shin, Alexei Lyzlov, Rasheed Ivey, Magda Shaheen, Samuel W. French, Amiya P. Sinha-Hikim. Additive Effects of Nicotine and High-Fat Diet on Hepatic Steatosis in Male Mice. Endocrinology 2012; 153(12): 5809 doi: 10.1210/en.2012-1750
|
| 306 |
Jonathan Meisel, Mark Puder, Hau Le, Vincent E. De Meijer, Kathleen Gura. Nutrition, Diet Therapy, and the Liver. 2009; : 81 doi: 10.1201/9781420085501.ch6
|
| 307 |
Heather C. Denroche, Whitney L. Quong, Jennifer E. Bruin, Eva Tudurí, Ali Asadi, Maria M. Glavas, Jessica K. Fox, Timothy J. Kieffer. Leptin Administration Enhances Islet Transplant Performance in Diabetic Mice. Diabetes 2013; 62(8): 2738 doi: 10.2337/db12-1684
|
| 308 |
Silvia Fargion, Marianna Porzio, Anna Ludovica Fracanzani. Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World Journal of Gastroenterology 2014; 20(37): 13306-13324 doi: 10.3748/wjg.v20.i37.13306
|
| 309 |
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Akihiro Ohbora, Takao Kojima, Michiaki Fukui. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017; 57(1): 89 doi: 10.1007/s12020-017-1313-6
|
| 310 |
Tomi Akinyemiju, Qingrui Meng, Neomi Vin-Raviv. Association between body mass index and in-hospital outcomes. Medicine 2016; 95(28): e4189 doi: 10.1097/MD.0000000000004189
|
| 311 |
C. D. Byrne. Dorothy Hodgkin Lecture 2012* Non‐alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabetic Medicine 2012; 29(9): 1098 doi: 10.1111/j.1464-5491.2012.03732.x
|
| 312 |
Koji Kikkawa, Katsuyuki Nakajima, Younosuke Shimomura, Yoshiharu Tokita, Tetsuo Machida, Hiroyuki Sumino, Masami Murakami. Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver. Clinica Chimica Acta 2015; 438: 70 doi: 10.1016/j.cca.2014.07.017
|
| 313 |
Adnan Said, Veronika Gagovic, Kristen Malecki, Marjory L. Givens, F. Javier Nieto. Primary care practitioners survey of non-alcoholic fatty liver disease. Annals of Hepatology 2013; 12(5): 758 doi: 10.1016/S1665-2681(19)31317-1
|
| 314 |
Arthur McCullough, Stephen F. Previs, Jaividhya Dasarathy, Kwangwon Lee, Abdullah Osme, Chunki Kim, Serguei Ilchenko, Shuhui W. Lorkowski, Jonathan D. Smith, Srinivasan Dasarathy, Takhar Kasumov. HDL flux is higher in patients with nonalcoholic fatty liver disease. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(5): E852 doi: 10.1152/ajpendo.00193.2019
|
| 315 |
Elia C El Hajj, Milad C El Hajj, Van K Ninh, Jason D Gardner. Featured Article: Cardioprotective effects of lysyl oxidase inhibition against volume overload-induced extracellular matrix remodeling. Experimental Biology and Medicine 2016; 241(5): 539 doi: 10.1177/1535370215616511
|
| 316 |
Tomas Koller, Jana Kollerova, Tibor Hlavaty, Martin Huorka, Juraj Payer. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scandinavian Journal of Gastroenterology 2012; 47(2): 197 doi: 10.3109/00365521.2011.643481
|
| 317 |
Satoshi Akabame, Masahide Hamaguchi, Ki-ichiro Tomiyasu, Muhei Tanaka, Yoshiko Kobayashi-Takenaka, Koji Nakano, Yohei Oda, Toshikazu Yoshikawa. Evaluation of Vulnerable Coronary Plaques and Non-Alcoholic Fatty Liver Disease (NAFLD) by 64-Detector Multislice Computed Tomography (MSCT). Circulation Journal 2007; 72(4): 618 doi: 10.1253/circj.72.618
|
| 318 |
Abazar Parsi, Eskandar Hajiani, Somayeh Sadani, Seid Jalal Hashemi, Seid Saeed Seyedian, Mehdi Alimadadi, Reza Ghanbari. Liver Fibrosis and Cirrhosis in Patients with Non-alcoholic Fatty Liver with and without History of Cholecystectomy: A Pilot Study. Middle East Journal of Digestive Diseases 2024; 16(1): 34 doi: 10.34172/mejdd.2024.366
|
| 319 |
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Naoto Nakamura, Akihiro Ohbora, Takao Kojima, Michiaki Fukui. BMI history and risk of incident fatty liver: a population-based large-scale cohort study. European Journal of Gastroenterology & Hepatology 2016; 28(10): 1188 doi: 10.1097/MEG.0000000000000682
|
| 320 |
Rachel P Wildman. Healthy obesity. Current Opinion in Clinical Nutrition and Metabolic Care 2009; 12(4): 438 doi: 10.1097/MCO.0b013e32832c6db7
|
| 321 |
Mehran Rahimlou, Zahra Yari, Azita Hekmatdoost, Seyed Moayed Alavian, Seyed Ali Keshavarz. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Hepatitis Monthly 2016; 16(1) doi: 10.5812/hepatmon.34897
|
| 322 |
Geri Brown. Mean Platelet Volumes in Non-Alcoholic Fatty Liver Disease (NAFLD): Relationship to Cardiovascular Events. Gastroenterology & Hepatology: Open Access 2016; 5(5) doi: 10.15406/ghoa.2016.05.00157
|
| 323 |
Ioanna Papagiouvanni, Marieta P. Theodorakopoulou, Pantelis A. Sarafidis, Emmanouil Sinakos, Ioannis Goulis. Peripheral endothelial and microvascular damage in liver cirrhosis: A systematic review and meta‐analysis. Microcirculation 2022; 29(4-5) doi: 10.1111/micc.12773
|
| 324 |
Ryan D. Sheldon, M. Harold Laughlin, R. Scott Rector. Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. Journal of Applied Physiology 2014; 116(9): 1156 doi: 10.1152/japplphysiol.01275.2013
|
| 325 |
Jiyun Oh, Hyun Jeong Park, Eun Sun Lee, Sung Bin Park, Byung Ihn Choi, Soohyun Ahn. Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression. Ultrasonography 2021; 40(4): 499 doi: 10.14366/usg.20122
|
| 326 |
Kristina R. Chacko, John Reinus. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2016; 20(2): 387 doi: 10.1016/j.cld.2015.10.004
|
| 327 |
Maurizio Delvecchio, Paola Muggeo, Mariantonietta Monteduro, Giuseppe Lassandro, Chiara Novielli, Federica Valente, Emanuela Salinaro, Annapaola Zito, Marco Matteo Ciccone, Vito Leonardo Miniello, Nicola Santoro, Paola Giordano, Maria Felicia Faienza. Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. European Journal of Endocrinology 2017; 176(2): 111 doi: 10.1530/EJE-16-0608
|
| 328 |
Jun-Hyuk Lee, Hye Sun Lee, A-Ra Cho, Yong-Jae Lee, Yu-Jin Kwon. Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level. International Journal of Environmental Research and Public Health 2021; 18(7): 3442 doi: 10.3390/ijerph18073442
|
| 329 |
Teruki Miyake, Teru Kumagi, Shinya Furukawa, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji. Non‐alcoholic fatty liver disease: Factors associated with its presence and onset. Journal of Gastroenterology and Hepatology 2013; 28(S4): 71 doi: 10.1111/jgh.12251
|
| 330 |
Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Jaw-Wen Chen, Hsin-Bang Leu. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clinical Biochemistry 2010; 43(18): 1399 doi: 10.1016/j.clinbiochem.2010.09.003
|
| 331 |
Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. International Journal of Environmental Research and Public Health 2019; 16(18): 3415 doi: 10.3390/ijerph16183415
|
| 332 |
Robert M. Wilechansky, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver International 2019; 39(8): 1535 doi: 10.1111/liv.14125
|
| 333 |
Nimer Assy, Agness Djibre, Raymond Farah, Maria Grosovski, Alon Marmor. Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease. Radiology 2010; 254(2): 393 doi: 10.1148/radiol.09090769
|
| 334 |
Kamrul M. Hasan, Theodore C. Friedman, Xuesi Shao, Meher Parveen, Carl Sims, Desean L. Lee, Jorge Espinoza‐Derout, Indrani Sinha‐Hikim, Amiya P. Sinha‐Hikim. E‐cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases. Hepatology 2019; 69(6): 2442 doi: 10.1002/hep.30512
|
| 335 |
Min-Sun Kwak, Donghee Kim. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. The Korean Journal of Internal Medicine 2018; 33(1): 64 doi: 10.3904/kjim.2017.343
|
| 336 |
Ki-Chul Sung, Sarah H. Wild, Hyon Joo Kwag, Christopher D. Byrne. Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome. Diabetes Care 2012; 35(11): 2359 doi: 10.2337/dc12-0515
|
| 337 |
Rick A Vreman, Alex J Goodell, Luis A Rodriguez, Travis C Porco, Robert H Lustig, James G Kahn. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. BMJ Open 2017; 7(8): e013543 doi: 10.1136/bmjopen-2016-013543
|
| 338 |
G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES. Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2010; 31(7): 679 doi: 10.1111/j.1365-2036.2009.04230.x
|
| 339 |
Ruth Chan, Vincent Wai-Sun Wong, Winnie Chiu-Wing Chu, Grace Lai-Hung Wong, Liz Sin Li, Jason Leung, Angel Mei-Ling Chim, David Ka-Wai Yeung, Mandy Man-Mei Sea, Jean Woo, Francis Ka-Leung Chan, Henry Lik-Yuen Chan, Susanne Kaser. Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong. PLOS ONE 2015; 10(4): e0122406 doi: 10.1371/journal.pone.0122406
|
| 340 |
Nazim Ghouri, David Preiss, Naveed Sattar. Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease: A Narrative Review and Clinical Perspective of Prospective Data†. Hepatology 2010; 52(3): 1156 doi: 10.1002/hep.23789
|
| 341 |
Min‐Sun Kwak, Kyung Won Kim, Hyobin Seo, Goh‐Eun Chung, Jeong Yoon Yim, Donghee Kim. Non‐obese fatty liver disease is associated with lacunar infarct. Liver International 2018; 38(7): 1292 doi: 10.1111/liv.13663
|
| 342 |
Raquel D. O. Conceicao, Ebenezer Oni, Antonio G. Laurinavicius, Raul D. Santos. Non Alcoholic Fatty Liver: Should We Care?. Current Cardiovascular Risk Reports 2014; 8(5) doi: 10.1007/s12170-014-0384-7
|
| 343 |
Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): 284 doi: 10.1016/j.clinre.2014.02.009
|
| 344 |
Miriam B. Vos, Stephanie H. Abrams, Sarah E. Barlow, Sonia Caprio, Stephen R. Daniels, Rohit Kohli, Marialena Mouzaki, Pushpa Sathya, Jeffrey B. Schwimmer, Shikha S. Sundaram, Stavra A. Xanthakos. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(2): 319 doi: 10.1097/MPG.0000000000001482
|
| 345 |
Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrology Dialysis Transplantation 2019; 34(3): 449 doi: 10.1093/ndt/gfx381
|
| 346 |
A Bazzocchi, D Diano, U Albisinni, G Marchesini, G Battista, G Guglielmi. Liver in the analysis of body composition by dual-energy X-ray absorptiometry. The British Journal of Radiology 2014; 87(1041): 20140232 doi: 10.1259/bjr.20140232
|
| 347 |
E. B. Tapper, K. Krajewski, M. Lai, T. Challies, R. Kane, N. Afdhal, D. Lau. Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterology Report 2014; 2(4): 276 doi: 10.1093/gastro/gou034
|
| 348 |
Tao Zhang, Chengqi Zhang, Yongyuan Zhang, Fang Tang, Hongkai Li, Qian Zhang, Haiyan Lin, Shuo Wu, Yanxun Liu, Fuzhong Xue. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study. Atherosclerosis 2015; 240(1): 144 doi: 10.1016/j.atherosclerosis.2015.02.049
|
| 349 |
Mika Aizawa, Seiichi Inagaki, Michiko Moriyama, Kenichiro Asano, Masayuki Kakehashi, Ying-Mei Feng. Modeling the natural history of fatty liver using lifestyle–related risk factors: Effects of body mass index (BMI) on the life–course of fatty liver. PLOS ONE 2019; 14(10): e0223683 doi: 10.1371/journal.pone.0223683
|
| 350 |
Anna Kotronen, Markku Peltonen, Antti Hakkarainen, Ksenia Sevastianova, Robert Bergholm, Lina M. Johansson, Nina Lundbom, Aila Rissanen, Martin Ridderstråle, Leif Groop, Marju Orho–Melander, Hannele Yki–Järvinen. Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors. Gastroenterology 2009; 137(3): 865 doi: 10.1053/j.gastro.2009.06.005
|
| 351 |
Manouchehr Khoshbaten, Sepideh H. Maleki, Sara Hadad, Amrit Baral, Ana V. Rocha, Laxmi Poudel, Alireza Abdshah. Association of nonalcoholic fatty liver disease and carotid media‐intima thickness: A systematic review and a meta‐analysis. Health Science Reports 2023; 6(9) doi: 10.1002/hsr2.1554
|
| 352 |
A. N. Mavrogiannaki, I. N. Migdalis. Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data. International Journal of Endocrinology 2013; 2013: 1 doi: 10.1155/2013/450639
|
| 353 |
Boren Jiang, Yingchao Chen, Kun Zhou, Yanjun Zheng, Yi Chen, Qin Li, Chunfang Zhu, Fangzhen Xia, Ting Gu, Yuyu Guo, Yingli Lu. Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. Obesity 2019; 27(5): 707 doi: 10.1002/oby.22432
|
| 354 |
Akira Tsuneto, Ayumi Hida, Nobuko Sera, Misa Imaizumi, Shinichiro Ichimaru, Eiji Nakashima, Shinji Seto, Koji Maemura, Masazumi Akahoshi. Fatty liver incidence and predictive variables. Hypertension Research 2010; 33(6): 638 doi: 10.1038/hr.2010.45
|
| 355 |
Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige, Atsushi Nakajima, Masashi Yoneda, Toshiji Saibara, Goshi Shiota, Isao Sakaida, Makoto Nakamuta, Toshihiko Mizuta, Hirohito Tsubouchi, Kentaro Sugano, Tooru Shimosegawa. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology Research 2015; 45(4): 363 doi: 10.1111/hepr.12511
|
| 356 |
Consuelo P. Vilar, Helma P. Cotrim, Gesira S. Florentino, Cibelle P.V. Barreto, André Vinicius A. Florentino, Gerson Bragagnoli, Paulo A. Schwingel. Association between nonalcoholic fatty liver disease and coronary artery disease. Revista da Associação Médica Brasileira 2013; 59(3): 290 doi: 10.1016/j.ramb.2012.11.006
|
| 357 |
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, Francesco Baratta, Paola Coletta, Michele Di Martino, Lorenzo Loffredo, Ludovica Perri, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Carlo Catalano, Marianna Maranghi, Maria Del Ben, Francesco Angelico, Marcello Arca. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. Atherosclerosis 2017; 257: 232 doi: 10.1016/j.atherosclerosis.2016.12.018
|
| 358 |
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Extrahepatic complications of non-alcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(4): 472 doi: 10.1016/j.rgmxen.2019.05.004
|
| 359 |
Yohei Asakawa, Hidehiro Takekawa, Keisuke Suzuki, Yuko Ishii, Masami Ohrui, Koichi Hirata. Relationship between Fatty Liver Disease and Intracranial Main Artery Stenosis. Internal Medicine 2014; 53(12): 1259 doi: 10.2169/internalmedicine.53.2067
|
| 360 |
Simona D’Amore, Giuseppe Palasciano, Antonio Moschetta. A Systems Biology Approach to Study Metabolic Syndrome. 2014; : 27 doi: 10.1007/978-3-319-01008-3_3
|
| 361 |
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak. Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study. Journal of Gastroenterology and Hepatology 2020; 35(5): 833 doi: 10.1111/jgh.14856
|
| 362 |
Enzo Bonora, Giovanni Targher. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nature Reviews Gastroenterology & Hepatology 2012; 9(7): 372 doi: 10.1038/nrgastro.2012.79
|
| 363 |
Lung-Yi Mak, James Fung. Non-alcoholic fatty liver disease in cerebrovascular disease: a bystander or a real risk factor?. Hepatology International 2022; 16(1): 24 doi: 10.1007/s12072-021-10273-9
|
| 364 |
Young-Je Kim, Dae Seong Yoon, Un Ju Jung. Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice. Nutrition Research and Practice 2021; 15(4): 431 doi: 10.4162/nrp.2021.15.4.431
|
| 365 |
G. Faria, A. Gonçalves, R. Cunha, J.T. Guimarães, C. Calhau, J. Preto, A. Taveira-Gomes. Beyond central adiposity: Liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients. International Journal of Surgery 2015; 14: 75 doi: 10.1016/j.ijsu.2014.12.028
|
| 366 |
Guoxin Huang, Hui Zhou, Chao Shen, Yihui Sheng, Ruyu Xue, Chen Dong, Shaoyan Zhang. Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults. Clinical and Experimental Hypertension 2021; 43(8): 750 doi: 10.1080/10641963.2021.1960364
|
| 367 |
Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar Stefan Björnsson, Matthew J. Armstrong, Laurence J. Hopkins, Xin Gao, Sven Francque, An Verrijken, Yusuf Yilmaz, Keith D. Lindor, Michael Charlton, Robin Haring, Markus M. Lerch, Rainer Rettig, Henry Völzke, Seungho Ryu, Guolin Li, Linda L. Wong, Mariana Machado, Helena Cortez-Pinto, Kohichiroh Yasui, Maurizio Cassader, Mark Woodward. Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis. PLoS Medicine 2014; 11(7): e1001680 doi: 10.1371/journal.pmed.1001680
|
| 368 |
|
| 369 |
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic. Nonalcoholic fatty liver disease - A multisystem disease?. World Journal of Gastroenterology 2016; 22(43): 9488-9505 doi: 10.3748/wjg.v22.i43.9488
|
| 370 |
Yu-Chen Guo, Yong Zhou, Xing Gao, Yan Yao, Bin Geng, Qing-Hua Cui, Ji-Chun Yang, Hong-Pu Hu. Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population. Chinese Medical Journal 2018; 131(19): 2269 doi: 10.4103/0366-6999.241797
|
| 371 |
Silvia Sookoian, Carlos J. Pirola. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review. Journal of Hepatology 2008; 49(4): 600 doi: 10.1016/j.jhep.2008.06.012
|
| 372 |
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12): 2809 doi: 10.1016/j.cgh.2021.12.002
|
| 373 |
|
| 374 |
L.M. Sarmiento Méndez, A. Roca-Cusachs Coll, J.A. Arroyo Díaz, M.T. Benet Gustà, M.J. Solé Villa, M. Franco Peral. Comparación de las definiciones de síndrome metabólico según ATP III e IDF. Revista Clínica Española 2008; 208(7): 333 doi: 10.1157/13124312
|
| 375 |
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular disease. Porto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
|
| 376 |
Prafulla Kumar Dash, Potapragoda Venkat Mohan, Nihar Ranjan Mohanty, Sukanta Kumar Jena. Association between Severity of Ultrasonographic Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in a Tertiary Care Teaching Hospital. Journal of Datta Meghe Institute of Medical Sciences University 2021; 16(4): 667 doi: 10.4103/jdmimsu.jdmimsu_479_21
|
| 377 |
Jiantao Ma, Shih-Jen Hwang, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Raymond T. Chung, Emelia J. Benjamin, Daniel Levy, Caroline S. Fox, Michelle T. Long. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. Journal of Hepatology 2017; 66(2): 390 doi: 10.1016/j.jhep.2016.09.022
|
| 378 |
Giovanni Targher, Christopher P. Day, Enzo Bonora. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. New England Journal of Medicine 2010; 363(14): 1341 doi: 10.1056/NEJMra0912063
|
| 379 |
Yoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, Muhei Tanaka, Masahiro Yamazaki, Michiaki Fukui. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. Endocrine Journal 2016; 63(10): 877 doi: 10.1507/endocrj.EJ16-0124
|
| 380 |
Takeshi Okanoue, Atsushi Umemura, Kohichiroh Yasui, Yoshito Itoh. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. Journal of Gastroenterology and Hepatology 2011; 26(s1): 153 doi: 10.1111/j.1440-1746.2010.06547.x
|
| 381 |
György Jermendy, Márton Kolossváry, Ibolya Dudás, Ádám L. Jermendy, Alexisz Panajotu, Imre F. Suhai, Zsófia D. Drobni, Júlia Karády, Ádám D. Tárnoki, Dávid L. Tárnoki, Szilard Voros, Béla Merkely, Pál Maurovich-Horvat. Effect of genetic and environmental influences on hepatic steatosis: A classical twin study based on computed tomography. Imaging 2020; 12(1): 15 doi: 10.1556/1647.2020.00006
|
| 382 |
Yiwen Zhang, Jun Xu, Xuemei Wang, Xinhua Ren, Yulan Liu. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. BMC Genomics 2019; 20(1) doi: 10.1186/s12864-019-6251-7
|
| 383 |
G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES. Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2010; 31(7): 679 doi: 10.1111/j.1365-2036.2009.04230.x
|
| 384 |
Kentaro Oniki, Masaharu Hori, Junji Saruwatari, Kazunori Morita, Ayami Kajiwara, Misaki Sakata, Shuichi Mihara, Yasuhiro Ogata, Kazuko Nakagawa. Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. Toxicology Letters 2013; 220(2): 143 doi: 10.1016/j.toxlet.2013.04.019
|
| 385 |
F. Fallo, A. Dalla Pozza, N. Sonino, M. Lupia, F. Tona, G. Federspil, M. Ermani, C. Catena, G. Soardo, L. Di Piazza, S. Bernardi, M. Bertolotto, B. Pinamonti, B. Fabris, L.A. Sechi. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutrition, Metabolism and Cardiovascular Diseases 2009; 19(9): 646 doi: 10.1016/j.numecd.2008.12.007
|
| 386 |
Hualing Zhai, Chi Chen, Ningjian Wang, Yi Chen, Xiaomin Nie, Bing Han, Qin Li, Fangzhen Xia, Yingli Lu. Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization. Environmental Health 2017; 16(1) doi: 10.1186/s12940-017-0304-7
|
| 387 |
S. Dora, G. Semikova, Z. Shvets, I. Cherebillo, N. Khoshafyan. Non-alcoholic fatty liver disease and its role in the development of cardiovascular diseases. Vrach 2023; 34(9): 44 doi: 10.29296/25877305-2023-11-10
|
| 388 |
Abazar Parsi, Mariya Torkashvand, Eskandar Hajiani, Mehran Rahimlou, Narges Sadeghi. The effects of crocus sativus extract on serum lipid profile and liver enzymes in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled study. Obesity Medicine 2020; 17: 100165 doi: 10.1016/j.obmed.2019.100165
|
| 389 |
Abdulrahman Ismaiel, Piero Portincasa, Dan L. Dumitrascu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 19 doi: 10.1007/978-3-031-33548-8_3
|
| 390 |
Peter Lykke Eriksen, Karen Louise Thomsen, Michael Sørensen, Hendrik Vilstrup, Anne-Mette Hvas. Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. Thrombosis Research 2022; 213: 9 doi: 10.1016/j.thromres.2022.02.023
|
| 391 |
Luan Rodrigues Abdallah, Ricardo Cardoso de Matos, Yves Pacheco Dias March e Souza, Débora Vieira-Soares, Gabriela Muller-Machado, Priscila Pollo-Flores. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. Current Atherosclerosis Reports 2020; 22(1) doi: 10.1007/s11883-020-0820-8
|
| 392 |
Satoshi HIRAKO, HyounJu KIM, Yuzuru IIZUKA, Akiyo MATSUMOTO. Fish oil consumption prevents hepatic lipid accumulation induced by high-cholesterol feeding in obese KK mice. Biomedical Research 2024; 45(1): 33 doi: 10.2220/biomedres.45.33
|
| 393 |
Angel Brea, José Puzo. Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology 2013; 167(4): 1109 doi: 10.1016/j.ijcard.2012.09.085
|
| 394 |
Giovanni Targher. Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk. Current Cardiovascular Risk Reports 2010; 4(1): 32 doi: 10.1007/s12170-009-0070-3
|
| 395 |
Derek Ugwendum, Mouhanad Mohamed, Yazan A Al-Ajlouni, Nso Nso, Basile Njei. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024; doi: 10.7759/cureus.62441
|
| 396 |
Thomas Heseltine, Scott Murray, Sandra Ortega-Martorell, Ivan Olier, Gregory Y.H. Lip, Saye Khoo. Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV–Heart Project. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021; 87(5): 1221 doi: 10.1097/QAI.0000000000002721
|
| 397 |
Jiantao Ma, Rachel Hennein, Chunyu Liu, Michelle T. Long, Udo Hoffmann, Paul F. Jacques, Alice H. Lichtenstein, Frank B. Hu, Daniel Levy. Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology 2018; 155(1): 107 doi: 10.1053/j.gastro.2018.03.038
|
| 398 |
Selena Z. Kuo, Sandra Cepin, Jaclyn Bergstrom, Harris Siddiqi, Jinho Jung, Scarlett Lopez, Daniel Q. Huang, Pam Taub, Maral Amangurbanova, Rohit Loomba. Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes. Alimentary Pharmacology & Therapeutics 2023; 58(6): 585 doi: 10.1111/apt.17637
|
| 399 |
Piia Simonen, Anna Kotronen, Maarit Hallikainen, Ksenia Sevastianova, Janne Makkonen, Antti Hakkarainen, Nina Lundbom, Tatu A. Miettinen, Helena Gylling, Hannele Yki-Järvinen. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. Journal of Hepatology 2011; 54(1): 153 doi: 10.1016/j.jhep.2010.05.037
|
| 400 |
Jake P. Mann, Paul Carter, Matthew J. Armstrong, Hesham K. Abdelaziz, Hardeep Uppal, Billal Patel, Suresh Chandran, Ranjit More, Philip N. Newsome, Rahul Potluri, Michael W. Greene. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. PLOS ONE 2020; 15(10): e0241357 doi: 10.1371/journal.pone.0241357
|